<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS Pathog</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plospath</journal-id>
<journal-title-group>
<journal-title>PLOS Pathogens</journal-title>
</journal-title-group>
<issn pub-type="ppub">1553-7366</issn>
<issn pub-type="epub">1553-7374</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.ppat.1006129</article-id>
<article-id pub-id-type="publisher-id">PPATHOGENS-D-16-01914</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Infectious diseases</subject><subj-group><subject>Bacterial diseases</subject><subj-group><subject>Salmonella</subject><subj-group><subject>Salmonella typhimurium</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Bacterial pathogens</subject><subj-group><subject>Salmonella</subject><subj-group><subject>Salmonella typhimurium</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Bacterial pathogens</subject><subj-group><subject>Salmonella</subject><subj-group><subject>Salmonella typhimurium</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Bacteria</subject><subj-group><subject>Enterobacteriaceae</subject><subj-group><subject>Salmonella</subject><subj-group><subject>Salmonella typhimurium</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pulmonology</subject><subj-group><subject>Respiratory infections</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Molecular biology</subject><subj-group><subject>Molecular biology techniques</subject><subj-group><subject>Artificial gene amplification and extension</subject><subj-group><subject>Polymerase chain reaction</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Molecular biology techniques</subject><subj-group><subject>Artificial gene amplification and extension</subject><subj-group><subject>Polymerase chain reaction</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Chemical compounds</subject><subj-group><subject>Electron acceptors</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Metabolism</subject><subj-group><subject>Metabolic processes</subject><subj-group><subject>Fermentation</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Digestive system</subject><subj-group><subject>Gastrointestinal tract</subject><subj-group><subject>Colon</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Digestive system</subject><subj-group><subject>Gastrointestinal tract</subject><subj-group><subject>Colon</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Digestive system</subject><subj-group><subject>Gastrointestinal tract</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Digestive system</subject><subj-group><subject>Gastrointestinal tract</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>DNA</subject><subj-group><subject>Operons</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Nucleic acids</subject><subj-group><subject>DNA</subject><subj-group><subject>Operons</subject></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Respiration of Microbiota-Derived 1,2-propanediol Drives <italic>Salmonella</italic> Expansion during Colitis</article-title>
<alt-title alt-title-type="running-head">1,2-propanediol-Utilization by <italic>Salmonella</italic></alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Faber</surname>
<given-names>Franziska</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6339-8744</contrib-id>
<name name-style="western">
<surname>Thiennimitr</surname>
<given-names>Parameth</given-names>
</name>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Spiga</surname>
<given-names>Luisella</given-names>
</name>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Byndloss</surname>
<given-names>Mariana X.</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-0183-2816</contrib-id>
<name name-style="western">
<surname>Litvak</surname>
<given-names>Yael</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-9154-8909</contrib-id>
<name name-style="western">
<surname>Lawhon</surname>
<given-names>Sara</given-names>
</name>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Andrews-Polymenis</surname>
<given-names>Helene L.</given-names>
</name>
<xref ref-type="aff" rid="aff005"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Winter</surname>
<given-names>Sebastian E.</given-names>
</name>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Bäumler</surname>
<given-names>Andreas J.</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Department of Medial Microbiology and Immunology, School of Medicine, University of California Davis, Davis, CA, United States of America</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX, United States of America</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>Department of Veterinary Pathobiology, College of Veterinary Medicine, Texas A&amp;M University, College Station, TX, United States of America</addr-line></aff>
<aff id="aff005"><label>5</label> <addr-line>Department of Microbial Pathogenesis and Immunology, College of Medicine, Texas A&amp;M University Health Science Center, Bryan, TX, United States of America</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Sperandio</surname>
<given-names>Vanessa</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>University of Texas Southwestern Medical Center, UNITED STATES</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con">
<p><list list-type="simple"> <list-item><p><bold>Conceptualization:</bold> FF PT SL HLAP SEW AJB.</p></list-item> <list-item><p><bold>Data curation:</bold> FF.</p></list-item> <list-item><p><bold>Formal analysis:</bold> FF PT MXB SL LS HLAP SEW.</p></list-item> <list-item><p><bold>Funding acquisition:</bold> PT SEW AJB.</p></list-item> <list-item><p><bold>Investigation:</bold> FF PT MXB LS YL SL HLAP.</p></list-item> <list-item><p><bold>Methodology:</bold> FF PT MXB SL LS YL HLAP SEW AJB.</p></list-item> <list-item><p><bold>Project administration:</bold> AJB.</p></list-item> <list-item><p><bold>Resources:</bold> SL HLAP LS SEW AJB.</p></list-item> <list-item><p><bold>Supervision:</bold> SL HLAP SEW AJB.</p></list-item> <list-item><p><bold>Validation:</bold> FF PT SEW AJB.</p></list-item> <list-item><p><bold>Visualization:</bold> FF AJB.</p></list-item> <list-item><p><bold>Writing – original draft:</bold> FF AJB.</p></list-item> <list-item><p><bold>Writing – review &amp; editing:</bold> FF AJB.</p></list-item></list>
</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">ajbaumler@ucdavis.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>5</day>
<month>1</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<month>1</month>
<year>2017</year>
</pub-date>
<volume>13</volume>
<issue>1</issue>
<elocation-id>e1006129</elocation-id>
<history>
<date date-type="received">
<day>16</day>
<month>8</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>12</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-year>2017</copyright-year>
<copyright-holder>Faber et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.ppat.1006129"/>
<abstract>
<p>Intestinal inflammation caused by <italic>Salmonella enterica</italic> serovar Typhimurium increases the availability of electron acceptors that fuel a respiratory growth of the pathogen in the intestinal lumen. Here we show that one of the carbon sources driving this respiratory expansion in the mouse model is 1,2-propanediol, a microbial fermentation product. 1,2-propanediol utilization required intestinal inflammation induced by virulence factors of the pathogen. <italic>S</italic>. Typhimurium used both aerobic and anaerobic respiration to consume 1,2-propanediol and expand in the murine large intestine. 1,2-propanediol-utilization did not confer a benefit in germ-free mice, but the <italic>pdu</italic> genes conferred a fitness advantage upon <italic>S</italic>. Typhimurium in mice mono-associated with <italic>Bacteroides fragilis</italic> or <italic>Bacteroides thetaiotaomicron</italic>. Collectively, our data suggest that intestinal inflammation enables <italic>S</italic>. Typhimurium to sidestep nutritional competition by respiring a microbiota-derived fermentation product.</p>
</abstract>
<abstract abstract-type="summary">
<title>Author Summary</title>
<p><italic>Salmonella enterica</italic> serovar Typhimurium induces intestinal inflammation to induce the generation of host-derived respiratory electron acceptors, thereby driving a respiratory pathogen expansion, which aids infectious transmission by the fecal oral route. However, the identity of nutrients serving as electron donors to enable <italic>S</italic>. Typhimurium to edge out competing microbes in the competitive environment of the gut are just beginning to be worked out. Here we demonstrate that aerobic and anaerobic respiratory pathways cooperate to promote growth of Salmonella on the microbial fermentation product 1,2-propanediol. We propose that pathogen-induced intestinal inflammation enables <italic>Salmonella</italic> to sidestep nutritional competition with the largely anaerobic microbiota by respiring a microbe-derived metabolite that cannot be consumed by fermentation.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000060</institution-id>
<institution>National Institute of Allergy and Infectious Diseases</institution>
</institution-wrap>
</funding-source>
<award-id>AI096528</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Baumler</surname>
<given-names>Andreas J.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award002">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000060</institution-id>
<institution>National Institute of Allergy and Infectious Diseases</institution>
</institution-wrap>
</funding-source>
<award-id>AI103248</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Winter</surname>
<given-names>Sebastian E.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award003">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100004396</institution-id>
<institution>Thailand Research Fund</institution>
</institution-wrap>
</funding-source>
<award-id>TRG5880041</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6339-8744</contrib-id>
<name name-style="western">
<surname>Thiennimitr</surname>
<given-names>Parameth</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>This work was supported by Public Health Service Grants AI096528 (AJB) and AI118807 (SEW) (<ext-link ext-link-type="uri" xlink:href="https://www.niaid.nih.gov/" xlink:type="simple">https://www.niaid.nih.gov/</ext-link>). PT was supported by Thailand Research Fund <ext-link ext-link-type="uri" xlink:href="http://www.trf.or.th/eng/" xlink:type="simple">http://www.trf.or.th/eng/</ext-link>, grant TRG5880041. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="5"/>
<table-count count="3"/>
<page-count count="19"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p><italic>Salmonella enterica</italic> serovar Typhimurium (<italic>S</italic>. Typhimurium) is a common cause of food poisoning. Upon ingestion, the pathogen enters the intestinal epithelium using the invasion-associated type III secretion system (T3SS-1) [<xref ref-type="bibr" rid="ppat.1006129.ref001">1</xref>] and deploys a second type III secretion system (T3SS-2) to survive in host tissue [<xref ref-type="bibr" rid="ppat.1006129.ref002">2</xref>]. This virulence strategy results in acute intestinal inflammation and diarrhea [<xref ref-type="bibr" rid="ppat.1006129.ref003">3</xref>]. Interestingly, gut inflammation increases the abundance of the pathogen within the gut-associated microbial community [<xref ref-type="bibr" rid="ppat.1006129.ref004">4</xref>] by generating a respiratory nutrient-niche (reviewed in [<xref ref-type="bibr" rid="ppat.1006129.ref005">5</xref>]). One respiratory electron acceptor generated as a byproduct of the inflammatory response is tetrathionate, which confers a luminal growth advantage upon <italic>S</italic>. Typhimurium in a mouse colitis model [<xref ref-type="bibr" rid="ppat.1006129.ref006">6</xref>] by enabling the pathogen to consume ethanolamine in the gut [<xref ref-type="bibr" rid="ppat.1006129.ref007">7</xref>].</p>
<p>Genes involved in tetrathionate respiration and ethanolamine-utilization are intact in <italic>Salmonella</italic> serovars associated with gastroenteritis in humans, but are often disrupted in <italic>Salmonella</italic> serovars associated with extraintestinal disease [<xref ref-type="bibr" rid="ppat.1006129.ref008">8</xref>–<xref ref-type="bibr" rid="ppat.1006129.ref010">10</xref>]. Another pathway often disrupted in <italic>Salmonella</italic> serovars associated with extraintestinal disease is the utilization 1,2-propanediol [<xref ref-type="bibr" rid="ppat.1006129.ref008">8</xref>–<xref ref-type="bibr" rid="ppat.1006129.ref010">10</xref>], which is produced during the fermentation of rhamnose or fucose [<xref ref-type="bibr" rid="ppat.1006129.ref011">11</xref>]. Genes required for the degradation of 1,2-propanediol are encoded by the <italic>porR pduF pduABCDEGHJKLMNOPQSTUVWX</italic> gene cluster [<xref ref-type="bibr" rid="ppat.1006129.ref012">12</xref>], a DNA region conserved among <italic>S</italic>. <italic>enterica</italic> serovars, but absent from the closely related species <italic>S</italic>. <italic>bongori</italic> [<xref ref-type="bibr" rid="ppat.1006129.ref013">13</xref>–<xref ref-type="bibr" rid="ppat.1006129.ref015">15</xref>]. Both ethanolamine and 1,2-propanediol-utilization proceeds through a pathway that requires a microcompartment, a respiratory electron acceptor and the cofactor cobalamin [<xref ref-type="bibr" rid="ppat.1006129.ref016">16</xref>]. Cobalamin biosynthesis genes are only expressed when <italic>S</italic>. Typhimurium is cultured under anaerobic or microaerobic conditions [<xref ref-type="bibr" rid="ppat.1006129.ref017">17</xref>, <xref ref-type="bibr" rid="ppat.1006129.ref018">18</xref>]. Under anaerobic conditions, tetrathionate can serve as an electron acceptor to support <italic>in vitro</italic> growth of <italic>S</italic>. Typhimurium on 1,2-propanediol and ethanolamine by using endogenously synthesized cobalamin [<xref ref-type="bibr" rid="ppat.1006129.ref019">19</xref>]. Based on these observations it has been proposed that tetrathionate respiration might enable <italic>S</italic>. Typhimurium to consume microbiota-derived 1,2-propanediol in the inflamed gut, thereby driving a luminal pathogen expansion [<xref ref-type="bibr" rid="ppat.1006129.ref020">20</xref>]. We analyzed the fitness of <italic>S</italic>. Typhimurium mutants in gnotobiotic or conventional mice to test this prediction.</p>
</sec>
<sec id="sec002" sec-type="results">
<title>Results</title>
<sec id="sec003">
<title>1,2-propanediol-utilization confers a growth advantage during inflammation</title>
<p>To determine whether 1,2-propanediol-utilization confers a benefit in the environment of the large intestine, we constructed a <italic>S</italic>. Typhimurium strain lacking the <italic>pduABCDEGHJKLMNOPQSTUVWX</italic> gene cluster (<italic>pduA-X</italic> mutant) (<xref ref-type="fig" rid="ppat.1006129.g001">Fig 1A</xref>). Compared to the <italic>S</italic>. Typhimurium wild type strain the <italic>pduA-X</italic> mutant grew poorly in minimal medium containing 1,2-propanediol as carbon source (<xref ref-type="fig" rid="ppat.1006129.g001">Fig 1B</xref>), but showed no growth defect in rich medium (<xref ref-type="supplementary-material" rid="ppat.1006129.s001">S1A Fig</xref>). Genetically resistant (CBA) mice were infected intragastrically with a 1:1 mixture of the <italic>S</italic>. Typhimurium wild type (IR715) and a <italic>pduA-X</italic> mutant (FF128) to compare the fitness of both strains. By 14 days after infection, the <italic>S</italic>. Typhimurium wild type was recovered in significantly higher numbers from cecal and colon contents than a <italic>pduA-X</italic> mutant (<italic>P</italic> &lt; 0.01), suggesting that 1,2-propanediol utilization conferred a benefit for growth of the pathogen in the large intestine (Figs <xref ref-type="fig" rid="ppat.1006129.g001">1C</xref> and <xref ref-type="supplementary-material" rid="ppat.1006129.s002">S2A</xref>). Similar results were obtained with a <italic>S</italic>. Typhimurium mutant carrying an insertion in the <italic>pduC</italic> gene (<xref ref-type="supplementary-material" rid="ppat.1006129.s001">S1B</xref> and <xref ref-type="supplementary-material" rid="ppat.1006129.s002">S2B</xref> Figs). After bypassing the gut by the intraperitoneal route of inoculation, the <italic>S</italic>. Typhimurium wild type was recovered in similar numbers as a <italic>pduA-X</italic> mutant from organs of mice infected with a 1:1 mixture of both strains (<xref ref-type="supplementary-material" rid="ppat.1006129.s002">S2C Fig</xref>). Growth of the <italic>pduA-X</italic> mutant in genetically resistant mice could be restored by re-introducing the intact <italic>pdu</italic> operon through transduction (FF484) (<xref ref-type="supplementary-material" rid="ppat.1006129.s002">S2D Fig</xref>).</p>
<fig id="ppat.1006129.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1006129.g001</object-id>
<label>Fig 1</label>
<caption>
<title>1,2-propanediol utilization confers an advantage during growth in the inflamed murine intestine.</title>
<p>(A) Genetic organization of the <italic>pdu</italic> operon. (B) Anaerobic growth of <italic>S</italic>. Typhimurium wild type and the <italic>pduA-X</italic> mutant in minimal medium supplemented with 5 mM 1,2-propanediol and 40 mM tetrathionate. Data points represent geometric means ± standard error of the mean (s.e.m.) of bacterial numbers (CFU/ml) recovered at the indicated time points. (C and E) CBA mice were mock infected (mock) or infected intragastrically with a 1:1 mixture of the indicated <italic>S</italic>. Typhimurium strains. <italic>N</italic> is indicated in panel E. (C) Bars represent geometric means ± s.e.m. of the competitive indices. (D) CBA mice were infected intragastrically with 10<sup>9</sup> CFU of either the <italic>S</italic>. Typhimurium wild type (wt) or a <italic>pduA-X</italic> mutant. <italic>N</italic> is indicated in <xref ref-type="supplementary-material" rid="ppat.1006129.s002">S2E Fig</xref>. Bars represent geometric means ± s.e.m. of bacteria recovered from colon contents (CFU/g). (E) Histopathological changes were scored in sections of the cecum. Each bar represents the combined scoring results for one individual animal. (F) Representative images of histological sections from the cecum. Scale bar represents 100 μm. M, mucosa; s, submucosa; ml, muscularis; * <italic>P</italic> &lt; 0.05, *** <italic>P</italic> &lt; 0.001.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006129.g001" xlink:type="simple"/>
</fig>
<p>Next, we infected mice with either the <italic>S</italic>. Typhimurium wild type or a <italic>pduA-X</italic> mutant. By 14 days, mice infected with the <italic>S</italic>. Typhimurium wild type carried a significantly higher pathogen burden in colon contents than mice infected with a <italic>pduA-X</italic> mutant (<italic>P</italic> &lt; 0.05) (<xref ref-type="fig" rid="ppat.1006129.g001">Fig 1D</xref>), although no significant differences in the severity of intestinal pathology between both groups were noted (<xref ref-type="supplementary-material" rid="ppat.1006129.s002">S2E Fig</xref>).</p>
<p>Since genetically resistant mice develop severe intestinal inflammation by approximately 10 days after infection [<xref ref-type="bibr" rid="ppat.1006129.ref021">21</xref>], we wanted to investigate whether the fitness advantage conferred by 1,2-propanediol utilization genes required severe colitis induced by virulence factors. To this end, T3SS-1 and T3SS-2 were inactivated using mutations in the <italic>invA</italic> and <italic>spiB</italic> genes, respectively. When mice (CBA) were infected intragastrically with a 1:1 mixture of an <italic>invA spiB</italic> mutant (FF183) and a <italic>invA spiB pduA-X</italic> mutant (FF383), both strains were recovered in similar numbers from cecal and colon contents 14 days after infection (<xref ref-type="fig" rid="ppat.1006129.g001">Fig 1C</xref>). Mice infected with virulent <italic>S</italic>. Typhimurium strains (i.e. a mixture of wild type and <italic>pduA-X</italic> mutant) developed severe acute inflammation in the cecal mucosa, while no marked inflammatory changes were observed in mice infected with avirulent <italic>S</italic>. Typhimurium strains (i.e. a mixture of <italic>invA spiB</italic> mutant and <italic>invA spiB pduA-X</italic> mutant) (<xref ref-type="fig" rid="ppat.1006129.g001">Fig 1E and 1F</xref>). These data suggested that the utilization of 1,2-propanediol conferred a fitness advantage upon <italic>S</italic>. Typhimurium during growth in the inflamed intestine.</p>
</sec>
<sec id="sec004">
<title>Tetrathionate respiration is dispensable for 1,2-propanediol-utilization <italic>in vivo</italic></title>
<p>A variety of exogenous electron acceptors can be generated during intestinal inflammation, including tetrathionate, nitrate, organic <italic>S-</italic>oxides (such as DMSO) or organic <italic>N-</italic>oxides (such as TMAO), which support growth by anaerobic respiration (summarized in [<xref ref-type="bibr" rid="ppat.1006129.ref022">22</xref>]). We next investigated whether exogenous electron acceptors would support anaerobic growth of <italic>S</italic>. Typhimurium on 1,2-propanediol <italic>in vitro</italic>. To this end, minimal medium containing 1,2-propanediol as the sole carbon source was supplemented with tetrathionate, nitrate, dimethyl sulfoxide (DMSO) or trimethylamine <italic>N</italic>-oxide (TMAO) and inoculated with a 1:1 mixture of the <italic>S</italic>. Typhimurium wild type and a <italic>pduA-X</italic> mutant. The ability to utilize 1,2-propanediol conferred the largest fitness advantage in media supplemented with tetrathionate, followed by media supplemented with nitrate, DMSO and TMAO (<xref ref-type="fig" rid="ppat.1006129.g002">Fig 2A</xref>). In contrast, 1,2-propanediol-utilization did not confer a growth advantage in the absence of exogenous electron acceptors, which was consistent with a previous report [<xref ref-type="bibr" rid="ppat.1006129.ref019">19</xref>]. Growth of the <italic>pduA-X</italic> mutant on 1,2-propanediol in media supplemented with tetrathionate could be restored by re-introducing the intact <italic>pdu</italic> operon through transduction (FF484).</p>
<fig id="ppat.1006129.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1006129.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Tetrathionate respiration supports growth of <italic>S</italic>. Typhimurium on 1,2-propanediol <italic>in vitro</italic>, but is not essential for 1,2-propanediol utilization <italic>in vivo</italic>.</title>
<p>(A) Competitive growth (<italic>N</italic> = 5) of the indicated <italic>S</italic>. Typhimurium strains on 1,2-propanediol under microaerobic conditions (0.8% oxygen) or anaerobically in the presence of tetrathionate (S<sub>4</sub>O<sub>6</sub><sup>2-</sup>), nitrate (NO<sub>3</sub><sup>-</sup>), dimethyl sulfoxide (DMSO) or trimethylamine <italic>N</italic>-oxide (TMAO). Bars represent geometric means ± s.e.m. of the competitive index (CI) recovered after 24 hours. (B) CBA/J mice (<italic>N</italic> = 4) were infected with a 1:1 mixture of the indicated <italic>S</italic>. Typhimurium strains. Bars represent geometric means ± s.e.m. of the CI. * <italic>P</italic> &lt; 0.05, NS not statistically significantly different; wt, <italic>S</italic>. Typhimurium wild type; <italic>pduA-X</italic>, <italic>pduA-X</italic> mutant; <italic>pduA-X</italic> restored, the intact <italic>pdu</italic> operon was introduced into the <italic>pduA-X</italic> mutant by transduction; <italic>ttrA</italic>, <italic>ttrA</italic> mutant; <italic>ttrA pduA-X</italic>, <italic>ttrA pduA-X</italic> mutant.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006129.g002" xlink:type="simple"/>
</fig>
<p>Since tetrathionate becomes available during inflammation [<xref ref-type="bibr" rid="ppat.1006129.ref006">6</xref>], it has been proposed that this electron acceptor might enable <italic>S</italic>. Typhimurium to utilize 1,2-propanediol during colitis [<xref ref-type="bibr" rid="ppat.1006129.ref020">20</xref>]. To test this prediction, we inactivated the <italic>ttrA</italic> gene, encoding tetrathionate reductase and infected genetically resistant (CBA) mice intragastrically with a 1:1 mixture of a <italic>S</italic>. Typhimurium <italic>ttrA</italic> mutant (SW661) and a <italic>ttrA pduA-X</italic> mutant (PT305). Surprisingly, 1,2-propanediol-utilization conferred a fitness advantage even after genetic ablation of tetrathionate respiration by a mutation in <italic>ttrA</italic> (<xref ref-type="fig" rid="ppat.1006129.g002">Fig 2B</xref>). These data refuted the hypothesis that tetrathionate respiration was necessary for the growth benefit conferred by 1,2-propanediol-utilization.</p>
</sec>
<sec id="sec005">
<title>Anaerobic respiration is not the only driver of 1,2-propanediol-utilization</title>
<p>The enzymes that enable <italic>S</italic>. Typhimurium to use tetrathionate, nitrate, organic <italic>S-</italic>oxides (such as DMSO) or organic <italic>N-</italic>oxides (such as TMAO) as respiratory electron acceptors under anaerobic conditions contain molybdopterin, a cofactor also required for the use of formate as an electron donor (reviewed in [<xref ref-type="bibr" rid="ppat.1006129.ref022">22</xref>]). To determine whether anaerobic respiration contributed to 1,2-propanediol-utilization, we inactivated the <italic>S</italic>. Typhimurium <italic>moaA</italic> gene, encoding the enzyme catalyzing the first step in the molybdopterin cofactor biosynthesis. Genetically resistant (CBA) mice were inoculated intragastrically with a 1:1 mixture of the <italic>S</italic>. Typhimurium wild type and a <italic>pduA-X</italic> mutant or with a 1:1 mixture of a <italic>moaA</italic> mutant (FF294) and a <italic>moaA pduA-X</italic> mutant (FF284). Interestingly, mutational inactivation of <italic>moaA</italic> did not abrogate the fitness advantage conferred by 1,2-propanediol-utilization (<xref ref-type="fig" rid="ppat.1006129.g003">Fig 3A</xref>). These data suggested that exogenous electron acceptors for anaerobic respiration were not solely responsible for the ability of <italic>S</italic>. Typhimurium to utilize 1,2-propanediol during colitis.</p>
<fig id="ppat.1006129.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1006129.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Aerobic and anaerobic respiration cooperates to support growth of <italic>S</italic>. Typhimurium on 1,2-propanediol in the inflamed intestine.</title>
<p>CBA mice (A) or streptomycin treated C57BL/6 mice (B) were orally infected with a 1:1 mixture of the indicated <italic>S</italic>. Typhimurium strains. Bars represent geometric means ± s.e.m. of the competitive indices determined at the indicated time points. (A) wt vs. <italic>pduA-X</italic>, <italic>N</italic> = 4; <italic>moaA</italic> vs. <italic>moaA pduA-X</italic>, <italic>N</italic> = 9; <italic>cyxA</italic> vs. <italic>cyxA pduA-X</italic>, <italic>N</italic> = 9; <italic>moaA cyxA</italic> vs. <italic>moaA cyxA pduA-X</italic>, <italic>N</italic> = 10. (B) wt vs. <italic>pduA-X</italic>, <italic>N</italic> = 4; <italic>invA spiB</italic> vs. <italic>invA spiB pduA-X</italic>, <italic>N</italic> = 6; <italic>moaA</italic> vs. <italic>moaA pduA-X</italic>, <italic>N</italic> = 5; <italic>cyxA</italic> vs. <italic>cyxA pduA-X</italic>, <italic>N</italic> = 6; <italic>moaA cyxA</italic> vs. <italic>moaA cyxA pduA-X</italic>, <italic>N</italic> = 5.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006129.g003" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec006">
<title>Aerobic and anaerobic respiration contribute to 1,2-propanediol-utilization</title>
<p><italic>S</italic>. Typhimurium-induced colitis is accompanied by increased epithelial oxygenation, driving a cytochrome <italic>bd-</italic>II oxidase-dependent aerobic pathogen expansion by 10 days after infection of genetically resistant (CBA) mice [<xref ref-type="bibr" rid="ppat.1006129.ref021">21</xref>]. We therefore deleted <italic>cyxA</italic>, the gene encoding cytochrome <italic>bd-</italic>II oxidase, to investigate whether aerobic respiration contributed to 1,2-propanediol-utilization. Genetically resistant (CBA) mice were inoculated intragastrically with a 1:1 mixture of a <italic>cyxA</italic> mutant (FF286) and a <italic>cyxA pduA-X</italic> mutant (FF288). Deletion of <italic>cyxA</italic> did not abrogate the fitness advantage conferred by 1,2-propanediol-utilization (<xref ref-type="fig" rid="ppat.1006129.g003">Fig 3A</xref>).</p>
<p>To determine whether 1,2-propanediol-utilization involved cooperation between aerobic and anaerobic respiration, genetically resistant (CBA) mice were infected with a 1:1 mixture of a <italic>cyxA moaA</italic> mutant (FF296) and a <italic>cyxA moaA pduA-X</italic> mutant (FF292). Remarkably, genetic ablation of both aerobic respiration (through inactivation of <italic>cyxA</italic>) and anaerobic respiration (through inactivation of <italic>moaA</italic>) abrogated the fitness advantage conferred by 1,2-propanediol-utilization (<italic>P</italic> 0.05) (<xref ref-type="fig" rid="ppat.1006129.g003">Fig 3A</xref>).</p>
<p>Next, we studied the role of 1,2-propanediol-utilization in mice that were genetically susceptible to <italic>S</italic>. Typhimurium infection (C57BL/6 mice). Genetically susceptible (C57BL/6) mice become moribund before developing severe acute intestinal inflammation during <italic>S</italic>. Typhimurium infection. However, preconditioning of C57BL/6 mice with streptomycin disrupts the resident microbiota and leads to severe acute cecal inflammation during <italic>S</italic>. Typhimurium infection [<xref ref-type="bibr" rid="ppat.1006129.ref023">23</xref>]. Streptomycin-treated C57BL/6 mice were infected intragastrically with a 1:1 mixture of the <italic>S</italic>. Typhimurium wild type and a <italic>pduA-X</italic> mutant or with a 1:1 mixture of an <italic>invA spiB</italic> mutant and a <italic>invA spiB pduA-X</italic> mutant. Four days after infection, 1,2-propanediol-utilization conferred a fitness advantage upon <italic>S</italic>. Typhimurium, as indicated by higher recovery of the wild type than a <italic>pduA-X</italic> mutant (<xref ref-type="fig" rid="ppat.1006129.g003">Fig 3B</xref> and <xref ref-type="supplementary-material" rid="ppat.1006129.s003">S3 Fig</xref>). In contrast, similar numbers of the <italic>invA spiB</italic> mutant and an <italic>invA spiB pduA-X</italic> mutant were recovered from colon contents. These data provided further support for the idea that benefit conferred by 1,2-propanediol-utilization required the presence of virulence factors.</p>
<p>In streptomycin-treated C57BL/6 mice, inactivation of either <italic>moaA</italic> or <italic>cyxA</italic> reduced the fitness advantage conferred by 1,2-propanediol-utilization (<xref ref-type="fig" rid="ppat.1006129.g003">Fig 3B</xref>). Collectively, these data provided further support for the idea that <italic>S</italic>. Typhimurium used both aerobic and anaerobic respiration to consume 1,2-propanediol during colitis.</p>
</sec>
<sec id="sec007">
<title><italic>Salmonella</italic> requires the gut microbiota to benefit from 1,2-propanediol-utilization</title>
<p>Saccharolytic bacteria in the large intestine break down complex carbohydrates, thereby liberating monosaccharides, such as fucose and rhamnose, which can be fermented to generate 1,2-propanediol [<xref ref-type="bibr" rid="ppat.1006129.ref011">11</xref>]. To investigate whether utilization of 1,2-propanediol by <italic>S</italic>. Typhimurium required members of the gut-associated microbial community, germ-free (Swiss-Webster) mice were infected with a 1:1 mixture of the <italic>S</italic>. Typhimurium wild type and a <italic>pduA-X</italic> mutant. Equal recovery of both strains from colon contents suggested that in the absence of the gut microbiota, 1,2-propanediol-utilization did not confer a luminal growth advantage in the mouse intestine (<xref ref-type="fig" rid="ppat.1006129.g004">Fig 4A and 4B</xref>). When mice mono-associated with <italic>Bacteroides fragilis</italic> or <italic>Bacteroides thetaiotaomicron</italic> were infected with a 1:1 mixture of the <italic>S</italic>. Typhimurium wild type and a <italic>pduA-X</italic> mutant, 1,2-propanediol-utilization conferred a fitness advantage (<xref ref-type="fig" rid="ppat.1006129.g004">Fig 4A and 4B</xref>), which was not due to changes in intestinal inflammation between the groups (<xref ref-type="fig" rid="ppat.1006129.g004">Fig 4C and 4D</xref>), suggesting that <italic>S</italic>. Typhimurium required the presence of saccharolytic bacteria to utilize 1,2-propanediol in the gut.</p>
<fig id="ppat.1006129.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1006129.g004</object-id>
<label>Fig 4</label>
<caption>
<title><italic>Salmonella</italic> requires the gut microbiota to benefit from 1,2-propanediol-utilization.</title>
<p>(A-B) Germ-free Swiss Webster mice or ex germ-free mice pre-colonized with either <italic>B</italic>. <italic>thetaiotaomicron</italic> (<italic>B</italic>. <italic>theta</italic>) or <italic>B</italic>. <italic>fragilis</italic> for 7 days were infected intragastrically with a 1:1 mixture of <italic>S</italic>. Typhimurium wild type and a <italic>pduA-X</italic> mutant. Bars represent geometric means ± s.e.m. of the competitive index (CI) recovered from colon contents (A) or cecal contents (B). <italic>N</italic> is indicated in panel C. (C) Histopathological changes were scored for sections of the cecum. (D) Representative images of histological sections from the cecum. Scale bar represents 100 μm. m, mucosa; s, submucosa; ml, muscularis. (E) Germ-free Swiss Webster mice or ex germ-free mice mono-associated with <italic>B</italic>. <italic>thetaiotaomicron</italic> for 7 days (<italic>N</italic> = 6) were infected intragastrically with the indicated <italic>S</italic>. Typhimurium strains and the 1,2-propanediol concentration was determined 3 days later. Bars represent geometric means ± s.e.m.; LOQ, limit of quantification. (F) Medium containing the sugars indicated at the top was inoculated with the <italic>S</italic>. Typhimurium strains indicated on the right. Sugar fermentation was detected through the color change (blue to yellow) of a pH indicator. (G) A <italic>pduC</italic> mutant or a <italic>fucO</italic> mutant was grown anaerobically in minimal medium containing fucose as a sole carbon source. The spent culture medium was supplemented with tetrathionate and inoculated with the indicated mixture of <italic>S</italic>. Typhimurium strains to determine the CI after anaerobic growth. (H) Germ-free mice (<italic>N</italic> = 4) were mono-associated with <italic>B</italic>. <italic>thetaiotaomicron</italic> and inoculated with the indicated strain mixtures. (G and H) Bars represent geometric means ± s.e.m. of the competitive index (CI).</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006129.g004" xlink:type="simple"/>
</fig>
<p>Next, we determined whether <italic>B</italic>. <italic>thetaiotaomicron</italic> was a source of 1,2-propanediol in the large intestine. To this end, germ-free mice were mock-inoculated or mono-associated with <italic>B</italic>. <italic>thetaiotaomicron</italic> and the concentration of 1,2-propanediol in colon contents was determined by gas chromatography/mass spectrometry (GC/MS). In mock-inoculated germ-free mice, the concentration of 1,2-propanediol was close to the limit of quantification. In contrast, 1,2-propanediol was present at a concentration of approximately 40 μM in <italic>B</italic>. <italic>thetaiotaomicron</italic> mono-associated mice (<xref ref-type="fig" rid="ppat.1006129.g004">Fig 4E</xref>). These data suggested that <italic>B</italic>. <italic>thetaiotaomicron</italic> is a source of 1,2-propanediol in the large intestine. To investigate whether consumption of 1,2-propanediol by <italic>S</italic>. Typhimurium would reduce the luminal concentration of this metabolite, mice mono-associated with <italic>B</italic>. <italic>thetaiotaomicron</italic> were infected with the <italic>S</italic>. Typhimurium wild type or a <italic>pduA-X</italic> mutant. While there was a trend that the luminal 1,2-propanediol concentrations were lower in mice infected with the wild type compared to those infected with the <italic>pduA-X</italic> mutant, this difference did not reach statistical significance (<xref ref-type="fig" rid="ppat.1006129.g004">Fig 4E</xref>).</p>
<p>Next, we determined whether the ability of the pathogen to generate 1,2-propanediol through fermentation of rhamnose or fucose was necessary for its ability to utilize 1,2-propanediol. To this end, we generated <italic>S</italic>. Typhimurium mutants lacking <italic>rhaBAD</italic> or <italic>fucO</italic>, respectively. A <italic>S</italic>. Typhimurium <italic>rhaBAD</italic> mutant was unable to ferment rhamnose (<xref ref-type="fig" rid="ppat.1006129.g004">Fig 4F</xref>), but exhibited no growth defect in complex culture medium (<xref ref-type="supplementary-material" rid="ppat.1006129.s001">S1C Fig</xref>). Inactivation of 1,2-propanediol utilization by deleting <italic>pduC</italic> or <italic>pduA-X</italic> did not abrogate the ability of <italic>S</italic>. Typhimurium to ferment rhamnose or fucose (<xref ref-type="fig" rid="ppat.1006129.g004">Fig 4F</xref>). The <italic>fucO</italic> gene encodes 1,2-propanediol oxidoreductase, the enzyme catalyzing the interconversion of lactaldehyde to 1,2-propanediol [<xref ref-type="bibr" rid="ppat.1006129.ref024">24</xref>]. Deletion of <italic>fucO</italic> did not abrogate the ability of <italic>S</italic>. Typhimurium to ferment fucose (<xref ref-type="fig" rid="ppat.1006129.g004">Fig 4F</xref>) and did not produce a growth defect in complex culture medium (<xref ref-type="supplementary-material" rid="ppat.1006129.s001">S1C Fig</xref>). We next generated spent culture medium by growing a <italic>pduC</italic> mutant or a <italic>fucO</italic> mutant anaerobically in minimal medium containing fucose as a sole carbon source. The spent culture medium generated in this fashion was sterilized, supplemented with tetrathionate and inoculated with a 1:1 mixture of the <italic>S</italic>. Typhimurium wild type and a <italic>pduC</italic> mutant. 1,2 propanediol-utilization did not confer a fitness advantage for anaerobic growth in spent culture medium from a <italic>fucO</italic> mutant (<xref ref-type="fig" rid="ppat.1006129.g004">Fig 4G</xref>), suggesting that the <italic>fucO</italic> mutant was no longer able to generate 1,2-propanediol as a product of fucose fermentation. We then investigated whether <italic>S</italic>. Typhimurium strains unable to generate 1,2-propanediol from fucose (<italic>fucO</italic> mutant), rhamnose (<italic>rhaBAD</italic> mutant) or either pentose (<italic>fucO rhaBAD</italic> mutant) were still able to use the <italic>pdu</italic> operon for expansion in the large intestine of gnotobiotic mice mono-associated with <italic>B</italic>. <italic>thetaiotaomicron</italic>. The <italic>pdu</italic> operon still conferred a significant fitness advantage upon <italic>S</italic>. Typhimurium strains that could generate 1,2-propanediol neither from fucose nor from rhamnose (<xref ref-type="fig" rid="ppat.1006129.g004">Fig 4H</xref>), suggesting that 1,2-propanediol generated by <italic>B</italic>. <italic>thetaiotaomicron</italic> (<xref ref-type="fig" rid="ppat.1006129.g004">Fig 4E</xref>) was sufficient to stimulate growth of the pathogen.</p>
<p>Collectively, these data demonstrated that microbe-derived 1,2 propanediol was a critical carbon source for <italic>S</italic>. Typhimurium, which drove an expansion of the pathogen population during colitis.</p>
</sec>
</sec>
<sec id="sec008" sec-type="conclusions">
<title>Discussion</title>
<p>Associations revealed by genome and literature mining predict that propanediol utilization pathways are genomic determinants of pathogenicity associated with food poisoning, presumably by promoting growth in the low-oxygen environment of the large intestine [<xref ref-type="bibr" rid="ppat.1006129.ref025">25</xref>]. For example, adherent-invasive <italic>Escherichia coli</italic> (AIEC) isolated from intestines of patients with Crohn's disease (CD) contain genes encoding 1,2-propanediol-utilization, while the gene cluster is commonly absent from commensal <italic>E</italic>. <italic>coli</italic> isolates [<xref ref-type="bibr" rid="ppat.1006129.ref026">26</xref>]. Comparative genomic analysis of <italic>S</italic>. <italic>enterica</italic> serovars suggest that loci involved in 1,2-propanediol utilization are intact in pathogens causing gastrointestinal disease, such as <italic>S</italic>. <italic>enterica</italic> serovars Typhimurium or Enteritidis, but are often disrupted in closely related pathogens associated exclusively with extraintestinal disease, such as <italic>S</italic>. <italic>enterica</italic> serovars Typhi, Paratyphi A, Gallinarum or Choleraesuis [<xref ref-type="bibr" rid="ppat.1006129.ref008">8</xref>–<xref ref-type="bibr" rid="ppat.1006129.ref010">10</xref>].</p>
<p><italic>S</italic>. Typhimurium growth under conditions mimicking the low-oxygen high-osmolarity environment of the gut induces the synthesis of proteins involved in the utilization of 1,2-propanediol [<xref ref-type="bibr" rid="ppat.1006129.ref027">27</xref>]. Transcriptional profiling suggests that 1,2-propanediol utilization genes are expressed during <italic>S</italic>. Typhimurium growth in the ceca of chickens [<xref ref-type="bibr" rid="ppat.1006129.ref028">28</xref>] and in gnotobiotic mice mono-associated with <italic>B</italic>. <italic>thetatiotaomicron</italic> [<xref ref-type="bibr" rid="ppat.1006129.ref029">29</xref>]. Collectively, studies on gene regulation and the <italic>in silico</italic> predictions reviewed above imply that 1,2-propanediol utilization genes might contribute to <italic>S</italic>. Typhimurium growth in the large intestine, but the present report is the first to test this hypothesis using an animal model. Our results provide compelling experimental support for the idea that 1,2-propanediol-utilization contributes to growth of <italic>S</italic>. Typhimurium during gastroenteritis, suggesting that the pathogen thrives during gut inflammation in part by respiring fermentation products generated by other microbes.</p>
<p>While tetrathionate respiration is necessary for growth on ethanolamine <italic>in vivo</italic> [<xref ref-type="bibr" rid="ppat.1006129.ref007">7</xref>], efficient 1,2-propanediol-utilization in the mouse intestine required both aerobic and anaerobic respiration. Interestingly, 1,2-propanediol represses transcription of ethanolamine utilization genes to avoid detrimental mixing of shell proteins from the corresponding microcompartments [<xref ref-type="bibr" rid="ppat.1006129.ref030">30</xref>]. Thus, the finding that different electron acceptors are required to breakdown 1,2-propanediol and ethanolamine <italic>in vivo</italic> may reflect the need to prevent simultaneous expression of the <italic>pdu</italic> and <italic>eut</italic> gene clusters. In turn, this may restrict utilization of 1,2-propanediol and ethanolamine to microenvironments that differ with regard to electron acceptor availability. However, additional work is needed to test this prediction.</p>
<p>1,2-propanediol is generated by the gut microbiota through fermentation of methyl-pentoses, such as fucose or rhamnose [<xref ref-type="bibr" rid="ppat.1006129.ref011">11</xref>]. Glycoside hydrolases and polysaccharide lyases expressed by the gut microbiota can liberate fucose from complex carbohydrates [<xref ref-type="bibr" rid="ppat.1006129.ref029">29</xref>] (<xref ref-type="fig" rid="ppat.1006129.g005">Fig 5</xref>). Members of the class <italic>Bacteroidia</italic> encode the most diverse array of glycoside hydrolases and polysaccharide lyases, suggesting that this group possesses the largest carbohydrate substrate range within the gut-associated microbial community [<xref ref-type="bibr" rid="ppat.1006129.ref031">31</xref>]. Consistent with this idea, 1,2-propanediol-utilization conferred a benefit upon <italic>S</italic>. Typhimurium in mice mono-associated with <italic>B</italic>. <italic>fragilis</italic> or <italic>B</italic>. <italic>thetaiotaomicron</italic>, but not in germ-free mice.</p>
<fig id="ppat.1006129.g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1006129.g005</object-id>
<label>Fig 5</label>
<caption>
<title>Schematic of <italic>S</italic>. Typhimurium 1,2-propanediol utilization during colitis.</title>
<p>The enteric pathogen <italic>S</italic>. Typhimurium (<italic>Salmonella</italic>) uses its virulence factors (T3SS-1 and T3SS-2) to elicit severe acute intestinal inflammation. A side-product of the host inflammatory response is the generation of exogenous electron acceptors, which creates a respiratory nutrient-niche in the lumen of the large intestine. A combination of aerobic and anaerobic respiration enables <italic>S</italic>. Typhimurium to expand in the inflamed intestine by consuming microbe-derived 1,2-propanediol, a metabolite produced during the fermentation of fucose or rhamnose. Monosaccharides, such as fucose and rhamnose, are liberated by the gut microbiota from complex carbohydrates, which escape digestion by host enzymes in the upper intestinal tract and reach the colon.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006129.g005" xlink:type="simple"/>
</fig>
<p>The picture emerging from this and previous work is that respiratory electron acceptors become available during <italic>S</italic>. Typhimurium-induced colitis [<xref ref-type="bibr" rid="ppat.1006129.ref006">6</xref>, <xref ref-type="bibr" rid="ppat.1006129.ref021">21</xref>, <xref ref-type="bibr" rid="ppat.1006129.ref032">32</xref>, <xref ref-type="bibr" rid="ppat.1006129.ref033">33</xref>], which enables the pathogen to consume 1,2-propanediol, a process that could be viewed as “dumpster diving” for a fermentation product produced by the gut microbiota [<xref ref-type="bibr" rid="ppat.1006129.ref034">34</xref>] (<xref ref-type="fig" rid="ppat.1006129.g005">Fig 5</xref>). Respiration of 1,2-propanediol allows <italic>S</italic>. Typhimurium to side-step nutritional competition with the fermenting gut microbiota to drive its expansion within the lumen of the large bowel. This outcome is biologically relevant, because an uncontrolled expansion of <italic>S</italic>. Typhimurium during colitis is important for infectious transmission by the fecal oral route [<xref ref-type="bibr" rid="ppat.1006129.ref021">21</xref>, <xref ref-type="bibr" rid="ppat.1006129.ref035">35</xref>].</p>
</sec>
<sec id="sec009" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="sec010">
<title>Ethics statement</title>
<p>This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health and approved by the Institutional Animal Care and Use Committee at the University of California at Davis (protocols #15449, 17140, 17939 and 19235).</p>
</sec>
<sec id="sec011">
<title>Bacterial strains and plasmids</title>
<p>All strains used in this study are listed in <xref ref-type="table" rid="ppat.1006129.t001">Table 1</xref>. <italic>S</italic>. Typhimurium and <italic>E</italic>. <italic>coli</italic> cultures were routinely grown aerobically at 37°C in either Luria-Bertani (LB) broth (10 g/l tryptone, 5 g/l yeast extract, 10 g/l NaCl) or on LB agar plates (1.5% Difco agar) unless indicated otherwise. When necessary, antibiotics were added to the medium at the following concentrations: Nalidixic acid (Nal) 50 mg/l, Kanamycin (Km) 100 mg/l, Chloramphenicol (Cm) 30 mg/l, Carbenicillin (Carb) 100 mg/L. <italic>B</italic>. <italic>thetaiotaomicron</italic> and <italic>B</italic>. <italic>fragilis</italic> were routinely grown inside an anaerobe chamber (Bactron I Anaerobic Chamber; Sheldon Manufacturing, Cornelius) at 37°C in either Tryptic Soy Broth (TSB) or on Tryptic Soy agar (TSA) plates (1.5% [w/v] Difco agar) supplemented with 5% (v/v) sheep blood.</p>
<table-wrap id="ppat.1006129.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1006129.t001</object-id>
<label>Table 1</label> <caption><title>Bacterial strains used in this study.</title></caption>
<alternatives>
<graphic id="ppat.1006129.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006129.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" style="background-color:#FFFFFF">Designation</th>
<th align="left" style="background-color:#FFFFFF">Genotype</th>
<th align="center" style="background-color:#FFFFFF">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" style="background-color:#FFFFFF"><bold><italic>S</italic>. Typhimurium strains</bold></td>
<td align="left" style="background-color:#FFFFFF"/>
<td align="center" style="background-color:#FFFFFF"/>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">IR715</td>
<td align="left" style="background-color:#FFFFFF">Nalidixic acid-resistant derivative of ATCC 14028s</td>
<td align="center" style="background-color:#FFFFFF">[<xref ref-type="bibr" rid="ppat.1006129.ref040">40</xref>]</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">FF176</td>
<td align="left" style="background-color:#FFFFFF">IR715 <italic>phoN</italic>::Tn<italic>10d-</italic>Cam</td>
<td align="center" style="background-color:#FFFFFF">[<xref ref-type="bibr" rid="ppat.1006129.ref041">41</xref>]</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">SPN487</td>
<td align="left" style="background-color:#FFFFFF">IR715 <italic>invA spiB</italic></td>
<td align="center" style="background-color:#FFFFFF">[<xref ref-type="bibr" rid="ppat.1006129.ref041">41</xref>]</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">FF183</td>
<td align="left" style="background-color:#FFFFFF">IR715 <italic>phoN</italic>::Tn<italic>10d-</italic>Cam <italic>invA spiB</italic></td>
<td align="center" style="background-color:#FFFFFF">[<xref ref-type="bibr" rid="ppat.1006129.ref041">41</xref>]</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">SDL175</td>
<td align="left" style="background-color:#FFFFFF">IR715 <italic>pduC</italic>::Kan<sup>R</sup></td>
<td align="left" style="background-color:#FFFFFF">This study</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">FF128</td>
<td align="left" style="background-color:#FFFFFF">IR715 <italic>pduA-X</italic>::Kan<sup>R</sup></td>
<td align="center" style="background-color:#FFFFFF">This study</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">FF383</td>
<td align="left" style="background-color:#FFFFFF">IR715 <italic>invA spiB pduA-X</italic>::Kan<sup>R</sup></td>
<td align="center" style="background-color:#FFFFFF">This study</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">SW661</td>
<td align="left" style="background-color:#FFFFFF">IR715 <italic>ttrA</italic>::pSW171</td>
<td align="center" style="background-color:#FFFFFF">[<xref ref-type="bibr" rid="ppat.1006129.ref006">6</xref>]</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">PT305</td>
<td align="left" style="background-color:#FFFFFF">IR715 <italic>ttrA</italic>::pSW171 <italic>pduA-X</italic>::Kan<sup>R</sup></td>
<td align="center" style="background-color:#FFFFFF">This study</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">FF283</td>
<td align="left" style="background-color:#FFFFFF">IR715 Δ<italic>moaA</italic></td>
<td align="center" style="background-color:#FFFFFF">This study</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">FR102</td>
<td align="left" style="background-color:#FFFFFF">IR715 <italic>cyxA</italic>::pPT48</td>
<td align="center" style="background-color:#FFFFFF">[<xref ref-type="bibr" rid="ppat.1006129.ref021">21</xref>]</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">FF294</td>
<td align="left" style="background-color:#FFFFFF">IR715 <italic>phoN</italic>::Tn<italic>10d-</italic>Cam Δ<italic>moaA</italic></td>
<td align="center" style="background-color:#FFFFFF">This study</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">FF284</td>
<td align="left" style="background-color:#FFFFFF">IR715 <italic>moaA pduA-X</italic>::Kan<sup>R</sup></td>
<td align="left" style="background-color:#FFFFFF">This study</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">FF286</td>
<td align="left" style="background-color:#FFFFFF">IR715 <italic>phoN</italic>::Tn<italic>10d-</italic>Cam <italic>cyxA</italic>::pPT48</td>
<td align="left" style="background-color:#FFFFFF">This study</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">FF288</td>
<td align="left" style="background-color:#FFFFFF">IR715 <italic>cyxA</italic>::pPT48 <italic>pduA-X</italic>::Kan<sup>R</sup></td>
<td align="left" style="background-color:#FFFFFF">This study</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">FF296</td>
<td align="left" style="background-color:#FFFFFF">IR715 <italic>phoN</italic>::Tn<italic>10d-</italic>Cam <italic>moaA cyxA</italic>::pPT48</td>
<td align="left" style="background-color:#FFFFFF">This study</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">FF292</td>
<td align="left" style="background-color:#FFFFFF">IR715 <italic>moaA cyxA</italic>::pPT48 <italic>pduA-X</italic>::Kan<sup>R</sup></td>
<td align="left" style="background-color:#FFFFFF">This study</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">FF489</td>
<td align="left" style="background-color:#FFFFFF">IR715 <italic>rhaBAD</italic></td>
<td align="left" style="background-color:#FFFFFF">This study</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">FF495</td>
<td align="left" style="background-color:#FFFFFF">IR715 <italic>rhaBAD pduA-X</italic>::Kan<sup>R</sup></td>
<td align="left" style="background-color:#FFFFFF">This study</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">FF499</td>
<td align="left" style="background-color:#FFFFFF">IR715 <italic>phoN</italic>::Tn<italic>10d-</italic>Cam <italic>rhaBAD</italic></td>
<td align="left" style="background-color:#FFFFFF">This study</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">PT206</td>
<td align="left" style="background-color:#FFFFFF">IR715 <italic>fucO</italic>::pPT21</td>
<td align="left" style="background-color:#FFFFFF">This study</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">FF509</td>
<td align="left" style="background-color:#FFFFFF">IR715 <italic>phoN</italic>::Tn<italic>10d-Cam fucO</italic>::pPT21</td>
<td align="left" style="background-color:#FFFFFF">This study</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">FF497</td>
<td align="left" style="background-color:#FFFFFF">IR715 <italic>fucO</italic>::pPT21 <italic>pduA-X</italic>::Kan<sup>R</sup></td>
<td align="left" style="background-color:#FFFFFF">This study</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">FF505</td>
<td align="left" style="background-color:#FFFFFF">IR715 <italic>phoN</italic>::Tn<italic>10d-Cam rhaBAD fucO</italic>::pPT21</td>
<td align="left" style="background-color:#FFFFFF">This study</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">FF503</td>
<td align="left" style="background-color:#FFFFFF">IR715 <italic>rhaBAD fucO</italic>::pPT21 <italic>pduA-X</italic>::Kan<sup>R</sup></td>
<td align="left" style="background-color:#FFFFFF">This study</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">FF480</td>
<td align="left" style="background-color:#FFFFFF">IR715 <italic>pduP</italic>::pRDH10</td>
<td align="left" style="background-color:#FFFFFF">This study</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">FF484</td>
<td align="left" style="background-color:#FFFFFF">FF128 restored to wild type</td>
<td align="left" style="background-color:#FFFFFF">This study</td>
</tr>
<tr>
<td align="left" colspan="3" style="background-color:#FFFFFF"><bold><italic>Bacteroides</italic> strains:</bold></td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF"><italic>B</italic>. <italic>thetaiotaomicron</italic> VPI-5482</td>
<td align="left" style="background-color:#FFFFFF">Isolate from human feces</td>
<td align="center" style="background-color:#FFFFFF">ATCC 29148</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF"><italic>B</italic>. <italic>fragilis</italic></td>
<td align="left" style="background-color:#FFFFFF">Isolate from appendix abscess</td>
<td align="center" style="background-color:#FFFFFF">ATCC25285</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF"><bold><italic>E</italic>. <italic>coli</italic> strains:</bold></td>
<td align="left" style="background-color:#FFFFFF"/>
<td align="center" style="background-color:#FFFFFF"/>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">DH5α λ<italic>pir</italic></td>
<td align="left" style="background-color:#FFFFFF">F<sup>-</sup> <italic>endA1 hsdR17</italic> (r<sup>-</sup>m<sup>+</sup>) <italic>supE44 thi-1 recA1 gyrA relA1</italic> Δ<italic>(lacZYA-argF)</italic><sub><italic>U189</italic></sub> <italic>ϕ80lac</italic> Δ<italic>M15</italic> λ<italic>pir</italic></td>
<td align="center" style="background-color:#FFFFFF">[<xref ref-type="bibr" rid="ppat.1006129.ref042">42</xref>]</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">S17-1 λ<italic>pir</italic></td>
<td align="left" style="background-color:#FFFFFF">C600::RP4 2-(Tet::<italic>Mu</italic>) (Kan::Tn7) λ<italic>pir recA1 thi pro hsdR</italic> (r<sup>-</sup>m<sup>+</sup>)</td>
<td align="center" style="background-color:#FFFFFF">[<xref ref-type="bibr" rid="ppat.1006129.ref043">43</xref>]</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">TOP10</td>
<td align="left" style="background-color:#FFFFFF"><italic>ϕ80lacZ</italic>Δ<italic>M15 lacX74 recA1 araD139</italic> Δ<italic>(ara-leu) 7697 galU galK rpsL endA1 nupG</italic></td>
<td align="center" style="background-color:#FFFFFF">Invitrogen</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
</sec>
<sec id="sec012">
<title>Construction of <italic>S</italic>. Typhimurium mutants</title>
<p>All strains, plasmids and primers used in this study are listed in Tables <xref ref-type="table" rid="ppat.1006129.t001">1</xref>–<xref ref-type="table" rid="ppat.1006129.t003">3</xref>. Standard cloning techniques were used to generate the plasmids used in this study. PCR products were confirmed by sequencing (SeqWright Fisher Scientific, Houston). Suicide plasmids were propagated in <italic>E</italic>. <italic>coli</italic> DH5α λ<italic>pir</italic>. Phage P22 HT <italic>int-105</italic> was used for generalized transduction. Transductants were cleaned from phage contamination on Evans blue-Uranine (EBU) plates and tested for phage sensitivity by cross-streaking against P22 H5.</p>
<table-wrap id="ppat.1006129.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1006129.t002</object-id>
<label>Table 2</label> <caption><title>Plasmids used in this study.</title></caption>
<alternatives>
<graphic id="ppat.1006129.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006129.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" style="background-color:#FFFFFF">Designation</th>
<th align="left" style="background-color:#FFFFFF">Relevant characteristic</th>
<th align="center" style="background-color:#FFFFFF">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" style="background-color:#FFFFFF">pCR2.1</td>
<td align="left" style="background-color:#FFFFFF">Cloning vector</td>
<td align="center" style="background-color:#FFFFFF">Invitrogen</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">pGP704</td>
<td align="left" style="background-color:#FFFFFF"><italic>ori</italic>(R6K) <italic>mobRP4</italic> Carb<sup>R</sup></td>
<td align="center" style="background-color:#FFFFFF">[<xref ref-type="bibr" rid="ppat.1006129.ref044">44</xref>]</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">pRDH10</td>
<td align="left" style="background-color:#FFFFFF"><italic>ori</italic>(R6K) <italic>mobRP4 sacRB</italic> Tet<sup>R</sup> Cm<sup>R</sup></td>
<td align="center" style="background-color:#FFFFFF">[<xref ref-type="bibr" rid="ppat.1006129.ref045">45</xref>]</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">pBS34</td>
<td align="left" style="background-color:#FFFFFF">pBluescript II KS+, KSAC cassette, Carb<sup>R</sup>, Km<sup>R</sup></td>
<td align="center" style="background-color:#FFFFFF">[<xref ref-type="bibr" rid="ppat.1006129.ref046">46</xref>]</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">pPT33</td>
<td align="left" style="background-color:#FFFFFF">pCR2.1 with region upstream of <italic>pduA</italic></td>
<td align="center" style="background-color:#FFFFFF">This study</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">pPT34</td>
<td align="left" style="background-color:#FFFFFF">pCR2.1 with region downstream of <italic>pduX</italic></td>
<td align="center" style="background-color:#FFFFFF">This study</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">pPT35</td>
<td align="left" style="background-color:#FFFFFF">pGP704 with region upstream of <italic>pduA</italic></td>
<td align="center" style="background-color:#FFFFFF">This study</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">pPT36</td>
<td align="left" style="background-color:#FFFFFF">pGP704 with regions upstream of <italic>pduA</italic> and downstream of <italic>pduX</italic></td>
<td align="center" style="background-color:#FFFFFF">This study</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">pPT37</td>
<td align="left" style="background-color:#FFFFFF">pGP704 with Kan<sup>R</sup> cassette inserted between p<italic>duA</italic> and <italic>pduX fragments</italic></td>
<td align="center" style="background-color:#FFFFFF">This study</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">pPT48</td>
<td align="left" style="background-color:#FFFFFF">pGP704 carrying an internal fragment of <italic>cyxA</italic> (annotated as STM14_0423 in ATCC 14028s)</td>
<td align="center" style="background-color:#FFFFFF">[<xref ref-type="bibr" rid="ppat.1006129.ref021">21</xref>]</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">pCAL25</td>
<td align="left" style="background-color:#FFFFFF">pRDH10 carrying up-/downstream regions of <italic>moaA</italic></td>
<td align="center" style="background-color:#FFFFFF">This study</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">pRhaBAD</td>
<td align="left" style="background-color:#FFFFFF">pRDH10 carrying flanking regions of <italic>rhaBAD</italic></td>
<td align="center" style="background-color:#FFFFFF">This study</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">pPT20</td>
<td align="left" style="background-color:#FFFFFF">pCR2.1 carrying an internal fragment of <italic>fucO</italic></td>
<td align="center" style="background-color:#FFFFFF">This study</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">pPT21</td>
<td align="left" style="background-color:#FFFFFF">pGP704 carrying an internal fragment of <italic>fucO</italic></td>
<td align="center" style="background-color:#FFFFFF">This study</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">pCR-pduP</td>
<td align="left" style="background-color:#FFFFFF">pCR2.1 carrying an internal fragment of <italic>pduP</italic></td>
<td align="center" style="background-color:#FFFFFF">This study</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">pRDH10-pduP</td>
<td align="left" style="background-color:#FFFFFF">pRDH10 carrying an internal fragment of <italic>pduP</italic></td>
<td align="center" style="background-color:#FFFFFF">This study</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">pKD4</td>
<td align="left" style="background-color:#FFFFFF">Carries the Kan<sup>R</sup> inserted in <italic>pduC</italic></td>
<td align="center" style="background-color:#FFFFFF">[<xref ref-type="bibr" rid="ppat.1006129.ref037">37</xref>]</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">pKD46</td>
<td align="left" style="background-color:#FFFFFF">Carries λ Red recombinase under an arabinose inducible promoter</td>
<td align="center" style="background-color:#FFFFFF">[<xref ref-type="bibr" rid="ppat.1006129.ref037">37</xref>]</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
<table-wrap id="ppat.1006129.t003" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1006129.t003</object-id>
<label>Table 3</label> <caption><title>Primers used in this study.</title></caption>
<alternatives>
<graphic id="ppat.1006129.t003g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006129.t003" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" style="background-color:#FFFFFF">Primer</th>
<th align="left" style="background-color:#FFFFFF">Sequence in 5’ - 3’</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="2" style="background-color:#FFFFFF"><italic>Deletion of pduA-X operon</italic></td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">pduA-P1</td>
<td align="left" style="background-color:#FFFFFF">TCTAGAAGACCTCGCATGGAG</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">pduA-P2</td>
<td align="left" style="background-color:#FFFFFF">GTCGACCATTGCGCCTTTAG</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">pduX-P3</td>
<td align="left" style="background-color:#FFFFFF">TCTAGAAGCCTGATATACGC</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">pduX-P4</td>
<td align="left" style="background-color:#FFFFFF">CCCGGGCTAACGATCGCCCAC</td>
</tr>
<tr>
<td align="left" colspan="2" style="background-color:#FFFFFF">Deletion of <italic>moaA</italic></td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">moaA-P1</td>
<td align="left" style="background-color:#FFFFFF">ATCTTAGTCGACGGCAGACTCAGTTCG</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">moaA-P2</td>
<td align="left" style="background-color:#FFFFFF">GACGAGTCTAGAGAGTGTTTACTGTGG</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">moaA-P3</td>
<td align="left" style="background-color:#FFFFFF">TAAGAATCTAGAGCGGCGAAGAAGACG</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">moaA-P4</td>
<td align="left" style="background-color:#FFFFFF">CCAGTTGTCGACTCAGTTCCTGTAAGC</td>
</tr>
<tr>
<td align="left" colspan="2" style="background-color:#FFFFFF">Deletion of <italic>pduC</italic></td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">STM20405'+P1</td>
<td align="left" style="background-color:#FFFFFF">CGATCGTCCGTCCTACATCTGATACCCACGAGGCTGATTCGTGTAGGCTGGAGCTGCTTC</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">STM20403'+P2</td>
<td align="left" style="background-color:#FFFFFF">CTGGCGCAGCAATTTTTCATTAATTTCCATTTCTCACCCCCATATGAATATCCTCCTTAG</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">STM2040 5'</td>
<td align="left" style="background-color:#FFFFFF">CTCGGTTCTGAACCGAAAAA</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">STM2040 3'</td>
<td align="left" style="background-color:#FFFFFF">CGGAGTACGTCTTCAATTAT</td>
</tr>
<tr>
<td align="left" colspan="2" style="background-color:#FFFFFF"><italic>Deletion of rhaBAD operon</italic></td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">rhaBAD-P1</td>
<td align="left" style="background-color:#FFFFFF">TCATGGCGACCACACCCGTCCTGTGTCAAACCGAAGGTTTCATC</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">rhaBAD -P2</td>
<td align="left" style="background-color:#FFFFFF">TGCCCGATTATTTCGAATACGCCGTTTATCG</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">rhaBAD -P3</td>
<td align="left" style="background-color:#FFFFFF">AACGGCGTATTCGAAATAATCGGGCATCAGCAG</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">rhaBAD -P4</td>
<td align="left" style="background-color:#FFFFFF">CGGCCACGATGCGTCCGGCGTAGAGAGCAAACACCGTACCCTG</td>
</tr>
<tr>
<td align="left" colspan="2" style="background-color:#FFFFFF"><italic>Deletion of fucO operon</italic></td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">fucO-P1</td>
<td align="left" style="background-color:#FFFFFF">GGTACCAGCGCTGATTGTTACCG</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">fucO-P2</td>
<td align="left" style="background-color:#FFFFFF">GATATCGCATGGGTTAGCGC</td>
</tr>
<tr>
<td align="left" colspan="2" style="background-color:#FFFFFF">Restoration of FF128 (<italic>pduA-X</italic>::Kan<sup>R</sup>)</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">pduP-P1</td>
<td align="left" style="background-color:#FFFFFF">GAATTCGCGTTATCGGTTCGG</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">pduP-P2</td>
<td align="left" style="background-color:#FFFFFF">GAATTCCTTTCACCAGGTCCGC</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
<p>To construct the <italic>pduA-X</italic> mutant (FF128), a region upstream and downstream of <italic>pduA and pduX</italic>, respectively, were PCR amplified from the <italic>S</italic>. Typhimurium wild-type strain IR715. Both PCR products (the flanking regions of <italic>pduA</italic> and <italic>pduX</italic> genes) were subcloned into pCR2.1 to obtain pPT33 and pPT34, respectively. The inserted PCR fragments were confirmed by sequencing. The <italic>pduA</italic> fragment from pPT33 was cloned into the suicide plasmid pGP704 by using SalI and XbaI restriction sites to obtain pPT35. The <italic>pduX</italic> fragment from pPT34 was digested by XbaI and SmaI and then inserted into pPT35 to yield pPT36. Next, the Kan<sup>r</sup> cassette from pBS34 was inserted into pPT36 to obtain pPT37. Plasmid pPT37 was transformed into <italic>E</italic>. <italic>coli</italic> S17-1λ<italic>pir</italic>. Plasmid pPT37 was conjugated into the <italic>S</italic>. Typhimurium wild type (IR715) and an <italic>invA spiB</italic> mutant (SPN487) using <italic>E</italic>. <italic>coli</italic> S17-1λ<italic>pir</italic> as a donor strain to generate FF128 (IR715 <italic>pduA-X</italic>::Kan<sup>R</sup>) and FF383 (IR715 <italic>invA spiB pduA-X</italic>::Kan<sup>R</sup>), respectively. Exconjugants were plated onto LB+Nal+Kan and tested for Carb<sup>S</sup> to select for clones that carried the deletion.</p>
<p>To construct the <italic>moaA</italic> mutant, a region upstream and downstream of <italic>moaA</italic> were PCR amplified from the <italic>S</italic>. Typhimurium wild-type strain IR715 introducing XbaI and SalI restriction sites into both fragments. Then, both PCR products were digested with XbaI ligated together and cloned into pRDH10 using SalI restriction sites yielding plasmid pCAL25. The inserted PCR fragments were confirmed by sequencing. Plasmid pCAL25 was conjugated into <italic>S</italic>. Typhimurium IR715 (wild-type) and FF176 (<italic>phoN</italic>::Tn10d-Cam) using <italic>E</italic>. <italic>coli</italic> S17-1λ<italic>pir</italic> as a donor strain to generate FF283 (IR715 <italic>moaA</italic>) and FF294 (<italic>phoN</italic>::Tn10d-Cam <italic>moaA</italic>), respectively. Exconjugants were plated onto LB+Nal+Cm to select for clones that had integrated the suicide plasmid. Sucrose counter-selection was performed as published previously [<xref ref-type="bibr" rid="ppat.1006129.ref036">36</xref>]. Strains that were sucrose resistant and Cm<sup>S</sup> were verified by PCR.</p>
<p>The <italic>pduC</italic> mutant was constructed using the λ Red recombinase method as previously described [<xref ref-type="bibr" rid="ppat.1006129.ref037">37</xref>]. PCR products were generated using primers STM20405’+P1 and STM20403’+S2 with pKD4 as the DNA template [<xref ref-type="bibr" rid="ppat.1006129.ref037">37</xref>]. The appropriate length of the PCR products, approximately 1.6 kb, was ensured by agarose gel electrophoresis. The PCR product was electroporated into electrocompetent ATCC14028 carrying pKD46, a temperature sensitive plasmid which carries λ Red recombinase under an arabinose inducible promoter [<xref ref-type="bibr" rid="ppat.1006129.ref037">37</xref>]. The recipient was prepared as previously described [<xref ref-type="bibr" rid="ppat.1006129.ref037">37</xref>]. Following electroporation, transformants were allowed to recover for 1 hour at 37°C and were then plated onto LB+Kan and grown at 37°C to select for clones that had integrated the PCR product. Insertion of the Kan<sup>R</sup> was confirmed by PCR using primers STM2040 5’ with previously described primer k1 and STM2040 3’ with primer k2 [<xref ref-type="bibr" rid="ppat.1006129.ref037">37</xref>]. The mutation was also confirmed by Southern blot using a digoxigenin-labeled probe generated by PCR using primers k1 and kt with pKD4 DNA as template. A P22 lysate of the resultant strain was used to transduce the <italic>pduC</italic>::Kan<sup>R</sup> into IR715 to generate SDL175.</p>
<p>To construct the <italic>rhaBAD</italic> mutant, regions flanking the <italic>rhaBAD</italic> operon were PCR amplified from the <italic>S</italic>. Typhimurium wild-type strain IR715 and cloned into BamHI-digested pRDH10 using Gibson Assembly Master Mix (NEB) yielding plasmid pRhaBAD. Plasmid pRhaBAD was conjugated into <italic>S</italic>. Typhimurium IR715 (wild-type) and FF128 (<italic>pduA-X</italic>::Kan<sup>R</sup>) using <italic>E</italic>. <italic>coli</italic> S17-1λ<italic>pir</italic> as a donor strain to generate FF489 (IR715 <italic>rhaBAD</italic>) and FF495 (<italic>rhaBAD pduA-X</italic>::Kan<sup>R</sup>), respectively. Exconjugants were plated onto LB+Nal+Cm to select for clones that had integrated the suicide plasmid. Sucrose counter-selection was performed as published previously [<xref ref-type="bibr" rid="ppat.1006129.ref036">36</xref>]. Strains that were sucrose resistant and Cm<sup>S</sup> were verified by PCR.</p>
<p>To construct the <italic>fucO</italic> mutant, an internal fragment of the <italic>fucO</italic> gene was PCR amplified from the <italic>S</italic>. Typhimurium wild-type strain IR715 and cloned into pCR2.1 to generate pPT20. The <italic>fucO</italic> fragment from pPT20 was cloned into suicide plasmid pGP704 to obtain pPT21. Using <italic>E</italic>. <italic>coli</italic> S17-1λ<italic>pir</italic> as a donor strain, plasmid pPT21 was conjugated into <italic>S</italic>. Typhimurium wild type (IR715), the <italic>phoN</italic>::Tn<italic>10d-Cam rhaBAD</italic> mutant (FF499) and the <italic>rhaBAD pduA-X</italic>::Kan<sup>R</sup> mutant (FF495) to generate PT206 (IR715 <italic>fucO</italic>::pPT21), FF505 (IR715 <italic>phoN</italic>::Tn<italic>10d-Cam rhaBAD fucO</italic>::pPT21) and FF503 (IR715 <italic>rhaBAD fucO</italic>::pPT21 <italic>pduA-X</italic>::Kan<sup>R</sup>), respectively. Exconjugants were plated onto LB+Nal+Carb to select for clones that carried the plasmid insertion.</p>
<p>A P22 lysate of strain FF128 was used to transduce the <italic>pduA-X</italic>::Kan<sup>R</sup> mutation into SW661 (<italic>ttrA</italic>), FF283 (<italic>moaA</italic>), FR102 (<italic>cyxA</italic>::pPT48) and PT206 (<italic>fucO</italic>::pPT21) to obtain strains PT305 (<italic>ttrA</italic>::pSW171 <italic>pduA-X</italic>::Kan<sup>R</sup>) FF284 (<italic>moaA pduA-X</italic>::Kan<sup>R</sup>), FF288 (<italic>cyxA</italic>::pPT48 <italic>pduA-X</italic>::Kan<sup>R</sup>) and FF497 (<italic>fucO</italic>::pPT21 <italic>pduA-X</italic>::Kan<sup>R</sup>), respectively.</p>
<p>A P22 lysate of strain FR102 was used to transduce the <italic>cyxA</italic>::pPT48 mutation into FF176 (<italic>phoN</italic>::Tn<italic>10d-</italic>Cam), FF294 <italic>phoN</italic>::Tn<italic>10d-</italic>Cam <italic>moaA</italic>) and FF284 (<italic>moaA pduA-X</italic>::Kan<sup>R</sup>) to generate strains FF286 (<italic>phoN</italic>::Tn<italic>10d-</italic>Cam <italic>cyxA</italic>::pPT48), FF296 (<italic>phoN</italic>::Tn<italic>10d-</italic>Cam <italic>moaA cyxA</italic>::pPT48) and FF292 (IR715 <italic>moaA cyxA</italic>::pPT48 <italic>pduA-X</italic>::Kan<sup>R)</sup>, respectively.</p>
<p>A P22 lysate of strain FF176 was used to transduce the <italic>phoN</italic>::Tn<italic>10d-</italic>Cam mutation into FF283 (IR715 <italic>moaA</italic>), FF489 (<italic>rhaBAD</italic>) and PT206 (<italic>fucO</italic>::pPT21) yielding strains FF294 (IR715 <italic>phoN</italic>::Tn<italic>10d-</italic>Cam <italic>moaA</italic>), FF499 (<italic>phoN</italic>::Tn<italic>10d-</italic>Cam <italic>rhaBAD</italic>) and FF509 (<italic>phoN</italic>::Tn<italic>10d-</italic>Cam <italic>fucO</italic>::pPT21), respectively.</p>
<p>To restore the <italic>pduA-X</italic>::Kan<sup>R</sup> mutant (FF128), an internal fragment of the <italic>pduP</italic> gene (part of the <italic>pduA-X</italic> operon) was PCR amplified from the <italic>S</italic>. Typhimurium wild-type strain IR715 and cloned into pCR2.1 to generate pCR-<italic>pduP</italic>. The <italic>pduP</italic> fragment from pCR2.1 was cloned into suicide plasmid pRDH10 to obtain pRDH10-pduP. Using <italic>E</italic>. <italic>coli</italic> S17-1λ<italic>pir</italic> as a donor strain, plasmid pRDH10-pduP was conjugated into <italic>S</italic>. Typhimurium wild type (IR715) yielding strain FF480. A P22 lysate of strain FF480 was used to transduce <italic>pduP</italic>::pRDH10 into FF128. Sucrose counter-selection was performed as published previously [<xref ref-type="bibr" rid="ppat.1006129.ref036">36</xref>]. Strains that were sucrose resistant and Cm<sup>S</sup> were verified by PCR.</p>
</sec>
<sec id="sec013">
<title><italic>In vitro</italic> growth assays</title>
<sec id="sec014">
<title>Anaerobic growth assays</title>
<p>Growth assays were performed in No-carbon-E (NCE) medium [<xref ref-type="bibr" rid="ppat.1006129.ref019">19</xref>] supplemented with trace metals (0.3 μM CaCl<sub>2</sub>, 0.1 μM ZnSO<sub>4</sub>, 0.045 μM FeSO<sub>4</sub>, 0.2 μM Na<sub>2</sub>Se<sub>2</sub>O<sub>3</sub>, 0.2 μM Na<sub>2</sub>MoO<sub>4</sub>, 2 μM MnSO<sub>4</sub>, 0.1 μM CuSO<sub>4</sub>, 3 μM CoCl<sub>2</sub>, 0.1 μM NiSO<sub>4</sub>) and 5 mM 1,2-propanediol (Sigma-Aldrich) as the sole carbon source. For anaerobic growth, cultures were incubated inside an anaerobe chamber with one of the following electron acceptors added to the medium: 40 mM sodium tetrathionate, 40 mM sodium nitrate, 40 mM dimethyl sulfoxide (DMSO) or 40 mM trimethylamine <italic>N</italic>-oxide (TMAO) (all purchased from Sigma-Aldrich). For microaerobic growth cultures were incubated inside a hypoxia chamber set at 0.8% oxygen. To enhance initial growth, media were inoculated with a single strain or with an equal mixture of indicated <italic>S</italic>. Typhimurium strains resuspended in LB and incubated at 37°C for 24 hours, which was based on a similar protocol [<xref ref-type="bibr" rid="ppat.1006129.ref038">38</xref>]. Bacterial numbers were determined by plating serial ten-fold dilutions onto LB agar containing the appropriate antibiotics. The ratios of recovered wild-type and mutant bacteria after 24 hours were normalized to the ratio at 0 hours to calculate the competitive index.</p>
</sec>
<sec id="sec015">
<title>Sugar fermentation assay</title>
<p>5 ml of fermentation broth (peptone, 10 g/l; Bromothymol blue, 0.024 g/l; final pH 7.4±0.1) supplemented with the indicated carbon source (galactarate, glucarate, galactose, glucose, mannose or rhamnose, 10g/L each) or the control broth (no sugar added) were inoculated with 10 μl of an over night culture of each indicated <italic>S</italic>. Typhimurium strain and incubated statically at 37°C for 24 hours. Fermentation of the sugar in the broth is indicated by a color change from blue to yellow.</p>
</sec>
</sec>
<sec id="sec016">
<title>Animal experiments</title>
<p>All animal experiments were approved by the Institutional Animal Care and Use Committees at the University of California, Davis. Female C57BL/6J and CBA/J wild-type mice aged 8–10 weeks were obtained from The Jackson Laboratory (Bar Harbor). Germ-free Swiss-Webster mice were bred in house.</p>
<p>C57BL/6 Mice were treated with an oral dose of 20 mg streptomycin 24 hours before oral infection with 0.1 ml LB broth (mock-infected) or with 1 x 10<sup>9</sup> CFU of a 1:1 mixture of the indicated <italic>S</italic>. Typhimurium strains. Mice were euthanized 4 days after infection, cecal and colon contents were collected for enumeration of bacterial numbers and the cecal tip was collected for histopathology scoring. Bacterial numbers were determined by plating serial ten-fold dilutions onto LB agar containing the appropriate antibiotics.</p>
<p>For intraperitoneal infection, C57BL/6 mice were injected with 10<sup>5</sup> CFU of a 1:1 mixture of the indicated <italic>S</italic>. Typhimurium strains. Mice were euthanized 2 days after infection and spleen, liver and mesenteric lymph nodes were collected for enumeration of bacterial numbers. Tissues were homogenized and bacterial numbers were determined by plating serial ten-fold dilutions onto LB agar containing the appropriate antibiotics.</p>
<p>CBA mice were infected with either 0.1 ml of LB broth (mock-infected) or <italic>S</italic>. Typhimurium in LB broth. For single infections, mice were inoculated with 1 x 10<sup>9</sup> CFU of the indicated <italic>S</italic>. Typhimurium strains. For competitive infections, mice were inoculated with 1 x 10<sup>9</sup> CFU of a 1:1 mixture of the indicated strains. Fecal pellets were collected at the indicated time points to monitor colonization over time. Mice were euthanized at 14 days after infection, cecal and colon contents were collected for enumeration of bacterial numbers and the cecal tip was collected for histopathology scoring. Bacterial numbers were determined by plating serial ten-fold dilutions onto LB agar containing the appropriate antibiotics.</p>
<p>Germ-free Swiss Webster mice were obtained from Taconic Farms. Mice were bred and housed under germ-free conditions inside gnotobiotic isolators (Park Bioservices, LLC). Weekly cultures were performed to monitor the germ-free status of the mice. For experiments, male and female 6–8 weeks old mice were transferred to a biosafety cabinet and maintained in sterile cages for the duration of the experiment. Each recipient germ-free mouse was orally inoculated with TSB (mock-infected) or the indicated <italic>Bacteroides</italic> strain resuspended in TSB. Mice were mono-colonized for 7 days with either <italic>B</italic>. <italic>thetaiotaomicron</italic> or <italic>B</italic>. <italic>fragilis</italic> before oral challenge with an equal mixture of 10<sup>9</sup> CFU of the indicated <italic>S</italic>. Typhimurium strains. Mice were euthanized 3 days after challenge with <italic>S</italic>. Typhimurium, cecal and colon contents were collected for enumeration of bacterial numbers and the cecal tip was collected for histopathology scoring. Bacterial numbers were determined by plating serial ten-fold dilutions onto LB agar containing the appropriate antibiotics.</p>
<p>When mice were infected with a 1:1 mixture of bacterial strains, the ratio of recovered bacterial strains was normalized to the ratio present in the inoculum to calculate the competitive index.</p>
</sec>
<sec id="sec017">
<title>Histopathology</title>
<p>Cecal tissue was fixed in 10% phosphate- buffered formalin and 5 μm sections of the tissue were stained with hematoxylin and eosin. Blinded scoring of tissue sections was performed by a veterinary pathologist based on the criteria listed in <xref ref-type="supplementary-material" rid="ppat.1006129.s004">S4 Fig</xref>. Representative images were taken using an Olympus BX41 microscope.</p>
</sec>
<sec id="sec018">
<title>1,2-propanediol measurements</title>
<p>Germ-free mice were orally inoculated with TSB (mock-infected) or <italic>B</italic>. <italic>thetaiotaomicron</italic> and colonized for 7 days before oral challenge with LB (mock-infected) or 10<sup>8</sup> CFU of <italic>S</italic>. Typhimurium wild-type or the <italic>pduA-X</italic> mutant. Mice were euthanized 3 days after challenge with <italic>S</italic>. Typhimurium and colon contents were collected in 250 μL of sterile PBS spiked with 0.1 mM (final concentration) of deuterated 1,2-propanediol (internal standard). The sample weights were measured for later normalizations to determine the correct concentration. Samples were vortexed for 2 minutes at maximum speed to break up the fecal pellet and create a homogenous solution. Samples were then centrifuged at 6,000 x g, 4°C for 15 minutes, the supernatant was transferred into a new tube and stored at -80°C for further processing. Samples, diluted with acetonitrile at a 1:1 ratio, were incubated for 30 min at room temperature. To remove particles, samples were centrifuged for 15 min at 20,000 g at 4°C. The supernatant was transferred to an autosampler vial for gas chromatography-mass spectrometry analysis. A Gas Chromatograph Mass Spectrometer (Shimadzu TQ-8040 GC/MS/MS) was used with an injection temperature of 250°C, injection split ratio of 5 and an injection volume of 1 μl. The GC oven temperature started at 100°C for 1 min, rising to 250°C at 10°C/min with a final hold at this temperature for 4 min. GC flow rate with helium carrier gas was constant at 35 cm/s. The GC column used was a 30 m × 0.25 mm × 0.25 μm Stabilwax-MS (Restek). The interface temperature was 250°C and ion source temperature was 200°C. The mass spectrometer was set to selected-ion monitoring of the three most abundant <italic>m</italic>/<italic>z</italic>, <italic>m/z</italic> 1 at 29, <italic>m/z</italic> 2 at 43, <italic>m/z</italic> 3 at 45 for 1,2-propanediol and <italic>m/z</italic> 1 at 30, <italic>m/z</italic> 2 at 33 and <italic>m/z</italic> 3 at 49 for the internal standard 1,2-propanediol-d<sub>6</sub>. <italic>m/z</italic> at 45 and <italic>m/z</italic> at 49 were used to quantify 1-2-propanediol and 1,2-propanediol-d<sub>6</sub> respectively, while the other m/z were used as qualifying ions [<xref ref-type="bibr" rid="ppat.1006129.ref039">39</xref>]. Recovery was calculated based on the internal standard. An external standard curve was run in triplicate for quantification.</p>
</sec>
<sec id="sec019">
<title>Statistical analysis</title>
<p>Student’s <italic>t</italic>-test was performed on logarithmically transformed values for bacterial numbers and competitive indices. A non-parametric test (Man Whitney) was used for comparing histopathology scores.</p>
</sec>
</sec>
<sec id="sec020">
<title>Supporting Information</title>
<supplementary-material id="ppat.1006129.s001" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006129.s001" xlink:type="simple">
<label>S1 Fig</label>
<caption>
<title>Growth of <italic>S</italic>. Typhimurium strains in rich medium.</title>
<p>(A-C) Rich medium (LB broth) was inoculated with one of the indicated <italic>S</italic>. Typhimurium strains and bacterial growth monitored by measuring the optical density at 600 nm (OD600). Each experiment was repeated three times independently.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="ppat.1006129.s002" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006129.s002" xlink:type="simple">
<label>S2 Fig</label>
<caption>
<title>The <italic>S</italic>. Typhimurium <italic>pduC</italic> mutant is attenuated during growth in the inflamed murine intestine, but not for growth in organs.</title>
<p>(A) CBA mice were infected intragastrically with a 1:1 mixture of the indicated <italic>S</italic>. Typhimurium strains. Bars represent geometric means ± s.e.m. of the CFU recovered for each strain at 14 days after infection. (B) CBA mice (<italic>N</italic> = 6) were infected intragastrically with a 1:1 mixture of <italic>S</italic>. Typhimurium wild type and a <italic>pduC</italic> mutant. (C) C57BL/6 mice (<italic>N</italic> = 4) were infected intraperitoneally with a 1:1 mixture of <italic>S</italic>. Typhimurium wild type and a <italic>pduA-X</italic> mutant. (D) CBA mice (<italic>N</italic> = 6) were infected intragastrically with a 1:1 mixture of a <italic>pduA-X</italic> mutant and a strain in which the <italic>pduA-X</italic> mutation had been restored by introducing the intact <italic>pdu</italic> operon through transduction. (A-C) Bars represent geometric means ± s.e.m. of the competitive indices. (E) Histopathological changes were scored in sections of the cecum for the experiment shown in <xref ref-type="fig" rid="ppat.1006129.g001">Fig 1D</xref>. Each bar represents the combined scoring results for one individual animal. *, <italic>P</italic> &lt; 0.05; **, <italic>P</italic> &lt; 0.01; MLN, mesenteric lymph node.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="ppat.1006129.s003" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006129.s003" xlink:type="simple">
<label>S3 Fig</label>
<caption>
<title>1,2-propanediol utilization confers a fitness advantage in C57BL/6 mice.</title>
<p>Streptomycin-treated C57BL/6 mice were infected intragastrically with a 1:1 mixture of the indicated <italic>S</italic>. Typhimurium strains. Bars represent geometric means ± s.e.m. of the CFU recovered for each strain at 4 days after infection.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="ppat.1006129.s004" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006129.s004" xlink:type="simple">
<label>S4 Fig</label>
<caption>
<title>Scoring criteria for the blinded examination of H&amp;E stained cecal tissue sections.</title>
<p>Criteria for blinded scoring performed by a veterinary pathologist.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="ppat.1006129.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Galán</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>Curtiss</surname> <given-names>R</given-names> <suffix>III</suffix></name>. <article-title>Cloning and molecular characterization of genes whose products allow <italic>Salmonella typhimurium</italic> to penetrate tissue culture cells</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>1989</year>;<volume>86</volume>:<fpage>6383</fpage>–<lpage>7</lpage>. <object-id pub-id-type="pmid">2548211</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hensel</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Shea</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>Gleeson</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Jones</surname> <given-names>MD</given-names></name>, <name name-style="western"><surname>Dalton</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Holden</surname> <given-names>DW</given-names></name>. <article-title>Simultaneous identification of bacterial virulence genes by negative selection</article-title>. <source>Science</source>. <year>1995</year>;<volume>269</volume>(<issue>5222</issue>):<fpage>400</fpage>–<lpage>3</lpage>. <object-id pub-id-type="pmid">7618105</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tsolis</surname> <given-names>RM</given-names></name>, <name name-style="western"><surname>Adams</surname> <given-names>LG</given-names></name>, <name name-style="western"><surname>Ficht</surname> <given-names>TA</given-names></name>, <name name-style="western"><surname>Baumler</surname> <given-names>AJ</given-names></name>. <article-title>Contribution of Salmonella typhimurium virulence factors to diarrheal disease in calves</article-title>. <source>Infect Immun</source>. <year>1999</year>;<volume>67</volume>(<issue>9</issue>):<fpage>4879</fpage>–<lpage>85</lpage>. Epub 1999/08/24.PubMed Central PMCID: PMC96822. <object-id pub-id-type="pmid">10456944</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stecher</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Robbiani</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Walker</surname> <given-names>AW</given-names></name>, <name name-style="western"><surname>Westendorf</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Barthel</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kremer</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota</article-title>. <source>PLoS Biol</source>. <year>2007</year>;<volume>5</volume>(<issue>10</issue>):<fpage>2177</fpage>–<lpage>89</lpage>. Epub 2007/09/01. 06-PLBI-RA-1801 [pii]. PubMed Central PMCID: PMC1951780. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pbio.0050244" xlink:type="simple">10.1371/journal.pbio.0050244</ext-link></comment> <object-id pub-id-type="pmid">17760501</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rivera-Chavez</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Baumler</surname> <given-names>AJ</given-names></name>. <article-title>The Pyromaniac Inside You: Salmonella Metabolism in the Host Gut</article-title>. <source>Annu Rev Microbiol</source>. <year>2015</year>;<volume>69</volume>:<fpage>31</fpage>–<lpage>48</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1146/annurev-micro-091014-104108" xlink:type="simple">10.1146/annurev-micro-091014-104108</ext-link></comment> <object-id pub-id-type="pmid">26002180</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Winter</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>Thiennimitr</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Winter</surname> <given-names>MG</given-names></name>, <name name-style="western"><surname>Butler</surname> <given-names>BP</given-names></name>, <name name-style="western"><surname>Huseby</surname> <given-names>DL</given-names></name>, <name name-style="western"><surname>Crawford</surname> <given-names>RW</given-names></name>, <etal>et al</etal>. <article-title>Gut inflammation provides a respiratory electron acceptor for Salmonella</article-title>. <source>Nature</source>. <year>2010</year>;<volume>467</volume>(<issue>7314</issue>):<fpage>426</fpage>–<lpage>9</lpage>. Epub 2010/09/25. nature09415 [pii]. PubMed Central PMCID: PMC2946174. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nature09415" xlink:type="simple">10.1038/nature09415</ext-link></comment> <object-id pub-id-type="pmid">20864996</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Thiennimitr</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Winter</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>Winter</surname> <given-names>MG</given-names></name>, <name name-style="western"><surname>Xavier</surname> <given-names>MN</given-names></name>, <name name-style="western"><surname>Tolstikov</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Huseby</surname> <given-names>DL</given-names></name>, <etal>et al</etal>. <article-title>Intestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiota</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2011</year>;<volume>108</volume>(<issue>42</issue>):<fpage>17480</fpage>–<lpage>5</lpage>. Epub 2011/10/05. 1107857108 [pii].PubMed Central PMCID: PMC3198331. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1107857108" xlink:type="simple">10.1073/pnas.1107857108</ext-link></comment> <object-id pub-id-type="pmid">21969563</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nuccio</surname> <given-names>SP</given-names></name>, <name name-style="western"><surname>Baumler</surname> <given-names>AJ</given-names></name>. <article-title>Comparative analysis of Salmonella genomes identifies a metabolic network for escalating growth in the inflamed gut</article-title>. <source>MBio</source>. <year>2014</year>;<volume>5</volume>(<issue>2</issue>):<fpage>e00929</fpage>–<lpage>14</lpage>. Epub 2014/03/20. PubMed Central PMCID: PMC3967523. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/mBio.00929-14" xlink:type="simple">10.1128/mBio.00929-14</ext-link></comment> <object-id pub-id-type="pmid">24643865</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Matthews</surname> <given-names>TD</given-names></name>, <name name-style="western"><surname>Schmieder</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Silva</surname> <given-names>GG</given-names></name>, <name name-style="western"><surname>Busch</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Cassman</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Dutilh</surname> <given-names>BE</given-names></name>, <etal>et al</etal>. <article-title>Genomic Comparison of the Closely-Related Salmonella enterica Serovars Enteritidis, Dublin and Gallinarum</article-title>. <source>PLoS One</source>. <year>2015</year>;<volume>10</volume>(<issue>6</issue>):<fpage>e0126883</fpage>. PubMed Central PMCID: PMCPMC4454671. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0126883" xlink:type="simple">10.1371/journal.pone.0126883</ext-link></comment> <object-id pub-id-type="pmid">26039056</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Langridge</surname> <given-names>GC</given-names></name>, <name name-style="western"><surname>Fookes</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Connor</surname> <given-names>TR</given-names></name>, <name name-style="western"><surname>Feltwell</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Feasey</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Parsons</surname> <given-names>BN</given-names></name>, <etal>et al</etal>. <article-title>Patterns of genome evolution that have accompanied host adaptation in Salmonella</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2015</year>;<volume>112</volume>(<issue>3</issue>):<fpage>863</fpage>–<lpage>8</lpage>. PubMed Central PMCID: PMCPMC4311825. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1416707112" xlink:type="simple">10.1073/pnas.1416707112</ext-link></comment> <object-id pub-id-type="pmid">25535353</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Badia</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Ros</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Aguilar</surname> <given-names>J</given-names></name>. <article-title>Fermentation mechanism of fucose and rhamnose in Salmonella typhimurium and Klebsiella pneumoniae</article-title>. <source>J Bacteriol</source>. <year>1985</year>;<volume>161</volume>(<issue>1</issue>):<fpage>435</fpage>–<lpage>7</lpage>. Epub 1985/01/01. PubMed Central PMCID: PMC214891. <object-id pub-id-type="pmid">3918008</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bobik</surname> <given-names>TA</given-names></name>, <name name-style="western"><surname>Havemann</surname> <given-names>GD</given-names></name>, <name name-style="western"><surname>Busch</surname> <given-names>RJ</given-names></name>, <name name-style="western"><surname>Williams</surname> <given-names>DS</given-names></name>, <name name-style="western"><surname>Aldrich</surname> <given-names>HC</given-names></name>. <article-title>The propanediol utilization (pdu) operon of Salmonella enterica serovar Typhimurium LT2 includes genes necessary for formation of polyhedral organelles involved in coenzyme B(12)-dependent 1, 2-propanediol degradation</article-title>. <source>J Bacteriol</source>. <year>1999</year>;<volume>181</volume>(<issue>19</issue>):<fpage>5967</fpage>–<lpage>75</lpage>. PubMed Central PMCID: PMCPMC103623. <object-id pub-id-type="pmid">10498708</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Porwollik</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Wong</surname> <given-names>RM</given-names></name>, <name name-style="western"><surname>McClelland</surname> <given-names>M</given-names></name>. <article-title>Evolutionary genomics of Salmonella: gene acquisitions revealed by microarray analysis</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2002</year>;<volume>99</volume>(<issue>13</issue>):<fpage>8956</fpage>–<lpage>61</lpage>. PubMed Central PMCID: PMCPMC124405. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.122153699" xlink:type="simple">10.1073/pnas.122153699</ext-link></comment> <object-id pub-id-type="pmid">12072558</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chan</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Baker</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>CC</given-names></name>, <name name-style="western"><surname>Detweiler</surname> <given-names>CS</given-names></name>, <name name-style="western"><surname>Dougan</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Falkow</surname> <given-names>S</given-names></name>. <article-title>Genomic comparison of Salmonella enterica serovars and Salmonella bongori by use of an S. enterica serovar typhimurium DNA microarray</article-title>. <source>J Bacteriol</source>. <year>2003</year>;<volume>185</volume>(<issue>2</issue>):<fpage>553</fpage>–<lpage>63</lpage>. PubMed Central PMCID: PMCPMC145314. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/JB.185.2.553-563.2003" xlink:type="simple">10.1128/JB.185.2.553-563.2003</ext-link></comment> <object-id pub-id-type="pmid">12511502</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Desai</surname> <given-names>PT</given-names></name>, <name name-style="western"><surname>Porwollik</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Long</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Cheng</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Wollam</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Bhonagiri-Palsikar</surname> <given-names>V</given-names></name>, <etal>et al</etal>. <article-title>Evolutionary Genomics of Salmonella enterica Subspecies</article-title>. <source>MBio</source>. <year>2013</year>;<volume>4</volume>(<issue>2</issue>). PubMed Central PMCID: PMCPMC3604774.</mixed-citation></ref>
<ref id="ppat.1006129.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jeter</surname> <given-names>RM</given-names></name>. <article-title>Cobalamin-dependent 1,2-propanediol utilization by Salmonella typhimurium</article-title>. <source>J Gen Microbiol</source>. <year>1990</year>;<volume>136</volume>(<issue>5</issue>):<fpage>887</fpage>–<lpage>96</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1099/00221287-136-5-887" xlink:type="simple">10.1099/00221287-136-5-887</ext-link></comment> <object-id pub-id-type="pmid">2166132</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jeter</surname> <given-names>RM</given-names></name>, <name name-style="western"><surname>Olivera</surname> <given-names>BM</given-names></name>, <name name-style="western"><surname>Roth</surname> <given-names>JR</given-names></name>. <article-title>Salmonella typhimurium synthesizes cobalamin (vitamin B12) de novo under anaerobic growth conditions</article-title>. <source>J Bacteriol</source>. <year>1984</year>;<volume>159</volume>(<issue>1</issue>):<fpage>206</fpage>–<lpage>13</lpage>. PubMed Central PMCID: PMCPMC215614. <object-id pub-id-type="pmid">6376471</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Andersson</surname> <given-names>DI</given-names></name>, <name name-style="western"><surname>Roth</surname> <given-names>JR</given-names></name>. <article-title>Redox regulation of the genes for cobinamide biosynthesis in Salmonella typhimurium</article-title>. <source>J Bacteriol</source>. <year>1989</year>;<volume>171</volume>(<issue>12</issue>):<fpage>6734</fpage>–<lpage>9</lpage>. PubMed Central PMCID: PMCPMC210570. <object-id pub-id-type="pmid">2687249</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Price-Carter</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Tingey</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Bobik</surname> <given-names>TA</given-names></name>, <name name-style="western"><surname>Roth</surname> <given-names>JR</given-names></name>. <article-title>The alternative electron acceptor tetrathionate supports B12-dependent anaerobic growth of Salmonella enterica serovar typhimurium on ethanolamine or 1,2-propanediol</article-title>. <source>J Bacteriol</source>. <year>2001</year>;<volume>183</volume>(<issue>8</issue>):<fpage>2463</fpage>–<lpage>75</lpage>. PubMed Central PMCID: PMCPMC95162. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/JB.183.8.2463-2475.2001" xlink:type="simple">10.1128/JB.183.8.2463-2475.2001</ext-link></comment> <object-id pub-id-type="pmid">11274105</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McNally</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Thomson</surname> <given-names>NR</given-names></name>, <name name-style="western"><surname>Reuter</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Wren</surname> <given-names>BW</given-names></name>. <article-title>'Add, stir and reduce': Yersinia spp. as model bacteria for pathogen evolution</article-title>. <source>Nat Rev Microbiol</source>. <year>2016</year>;<volume>14</volume>(<issue>3</issue>):<fpage>177</fpage>–<lpage>90</lpage>. Epub 2016/02/16. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nrmicro.2015.29" xlink:type="simple">10.1038/nrmicro.2015.29</ext-link></comment> <object-id pub-id-type="pmid">26876035</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rivera-Chavez</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>LF</given-names></name>, <name name-style="western"><surname>Faber</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Lopez</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Byndloss</surname> <given-names>MX</given-names></name>, <name name-style="western"><surname>Olsan</surname> <given-names>EE</given-names></name>, <etal>et al</etal>. <article-title>Depletion of Butyrate-Producing Clostridia from the Gut Microbiota Drives an Aerobic Luminal Expansion of Salmonella</article-title>. <source>Cell Host Microbe</source>. <year>2016</year>;<volume>19</volume>(<issue>4</issue>):<fpage>443</fpage>–<lpage>54</lpage>. PubMed Central PMCID: PMCPMC4832419. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.chom.2016.03.004" xlink:type="simple">10.1016/j.chom.2016.03.004</ext-link></comment> <object-id pub-id-type="pmid">27078066</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Winter</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>Lopez</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Baumler</surname> <given-names>AJ</given-names></name>. <article-title>The dynamics of gut-associated microbial communities during inflammation</article-title>. <source>EMBO Rep</source>. <year>2013</year>;<volume>14</volume>(<issue>4</issue>):<fpage>319</fpage>–<lpage>27</lpage>. PubMed Central PMCID: PMCPMC3615657. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/embor.2013.27" xlink:type="simple">10.1038/embor.2013.27</ext-link></comment> <object-id pub-id-type="pmid">23478337</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barthel</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hapfelmeier</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Quintanilla-Martinez</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Kremer</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Rohde</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hogardt</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host</article-title>. <source>Infect Immun</source>. <year>2003</year>;<volume>71</volume>(<issue>5</issue>):<fpage>2839</fpage>–<lpage>58</lpage>. Epub 2003/04/22. PubMed Central PMCID: PMC153285. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/IAI.71.5.2839-2858.2003" xlink:type="simple">10.1128/IAI.71.5.2839-2858.2003</ext-link></comment> <object-id pub-id-type="pmid">12704158</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Blikstad</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Widersten</surname> <given-names>M</given-names></name>. <article-title>Functional characterization of a stereospecific diol dehydrogenase, FucO, from Escherichia coli: Substrate specificity, pH dependence, kinetic isotope effects and influence of solvent viscosity</article-title>. <source>JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC</source>. <year>2010</year>;<volume>66</volume>(<issue>1–2</issue>):<fpage>148</fpage>–<lpage>55</lpage>.</mixed-citation></ref>
<ref id="ppat.1006129.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Korbel</surname> <given-names>JO</given-names></name>, <name name-style="western"><surname>Doerks</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Jensen</surname> <given-names>LJ</given-names></name>, <name name-style="western"><surname>Perez-Iratxeta</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Kaczanowski</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Hooper</surname> <given-names>SD</given-names></name>, <etal>et al</etal>. <article-title>Systematic association of genes to phenotypes by genome and literature mining</article-title>. <source>PLoS Biol</source>. <year>2005</year>;<volume>3</volume>(<issue>5</issue>):<fpage>e134</fpage>. PubMed Central PMCID: PMCPMC1073694. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pbio.0030134" xlink:type="simple">10.1371/journal.pbio.0030134</ext-link></comment> <object-id pub-id-type="pmid">15799710</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dogan</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Suzuki</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Herlekar</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Sartor</surname> <given-names>RB</given-names></name>, <name name-style="western"><surname>Campbell</surname> <given-names>BJ</given-names></name>, <name name-style="western"><surname>Roberts</surname> <given-names>CL</given-names></name>, <etal>et al</etal>. <article-title>Inflammation-associated adherent-invasive Escherichia coli are enriched in pathways for use of propanediol and iron and M-cell translocation</article-title>. <source>Inflamm Bowel Dis</source>. <year>2014</year>;<volume>20</volume>(<issue>11</issue>):<fpage>1919</fpage>–<lpage>32</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/MIB.0000000000000183" xlink:type="simple">10.1097/MIB.0000000000000183</ext-link></comment> <object-id pub-id-type="pmid">25230163</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sonck</surname> <given-names>KA</given-names></name>, <name name-style="western"><surname>Kint</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Schoofs</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Vander Wauven</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Vanderleyden</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>De Keersmaecker</surname> <given-names>SC</given-names></name>. <article-title>The proteome of Salmonella Typhimurium grown under in vivo-mimicking conditions</article-title>. <source>Proteomics</source>. <year>2009</year>;<volume>9</volume>(<issue>3</issue>):<fpage>565</fpage>–<lpage>79</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/pmic.200700476" xlink:type="simple">10.1002/pmic.200700476</ext-link></comment> <object-id pub-id-type="pmid">19137547</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Harvey</surname> <given-names>PC</given-names></name>, <name name-style="western"><surname>Watson</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hulme</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Jones</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Lovell</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Berchieri</surname> <given-names>A</given-names> <suffix>Jr.</suffix></name>, <etal>et al</etal>. <article-title>Salmonella enterica serovar typhimurium colonizing the lumen of the chicken intestine grows slowly and upregulates a unique set of virulence and metabolism genes</article-title>. <source>Infect Immun</source>. <year>2011</year>;<volume>79</volume>(<issue>10</issue>):<fpage>4105</fpage>–<lpage>21</lpage>. PubMed Central PMCID: PMCPMC3187277. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/IAI.01390-10" xlink:type="simple">10.1128/IAI.01390-10</ext-link></comment> <object-id pub-id-type="pmid">21768276</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ng</surname> <given-names>KM</given-names></name>, <name name-style="western"><surname>Ferreyra</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Higginbottom</surname> <given-names>SK</given-names></name>, <name name-style="western"><surname>Lynch</surname> <given-names>JB</given-names></name>, <name name-style="western"><surname>Kashyap</surname> <given-names>PC</given-names></name>, <name name-style="western"><surname>Gopinath</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens</article-title>. <source>Nature</source>. <year>2013</year>;<volume>502</volume>(<issue>7469</issue>):<fpage>96</fpage>–<lpage>9</lpage>. Epub 2013/09/03. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nature12503" xlink:type="simple">10.1038/nature12503</ext-link></comment> <object-id pub-id-type="pmid">23995682</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sturms</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Streauslin</surname> <given-names>NA</given-names></name>, <name name-style="western"><surname>Cheng</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Bobik</surname> <given-names>TA</given-names></name>. <article-title>In Salmonella enterica, Ethanolamine Utilization Is Repressed by 1,2-Propanediol To Prevent Detrimental Mixing of Components of Two Different Bacterial Microcompartments</article-title>. <source>J Bacteriol</source>. <year>2015</year>;<volume>197</volume>(<issue>14</issue>):<fpage>2412</fpage>–<lpage>21</lpage>. PubMed Central PMCID: PMCPMC4524194. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/JB.00215-15" xlink:type="simple">10.1128/JB.00215-15</ext-link></comment> <object-id pub-id-type="pmid">25962913</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>El Kaoutari</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Armougom</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Gordon</surname> <given-names>JI</given-names></name>, <name name-style="western"><surname>Raoult</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Henrissat</surname> <given-names>B</given-names></name>. <article-title>The abundance and variety of carbohydrate-active enzymes in the human gut microbiota</article-title>. <source>Nat Rev Microbiol</source>. <year>2013</year>;<volume>11</volume>(<issue>7</issue>):<fpage>497</fpage>–<lpage>504</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nrmicro3050" xlink:type="simple">10.1038/nrmicro3050</ext-link></comment> <object-id pub-id-type="pmid">23748339</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lopez</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Rivera-Chavez</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Byndloss</surname> <given-names>MX</given-names></name>, <name name-style="western"><surname>Baumler</surname> <given-names>AJ</given-names></name>. <article-title>The Periplasmic Nitrate Reductase NapABC Supports Luminal Growth of Salmonella enterica Serovar Typhimurium during Colitis</article-title>. <source>Infect Immun</source>. <year>2015</year>;<volume>83</volume>(<issue>9</issue>):<fpage>3470</fpage>–<lpage>8</lpage>. Epub 2015/06/24. PubMed Central PMCID: PMC4534643. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/IAI.00351-15" xlink:type="simple">10.1128/IAI.00351-15</ext-link></comment> <object-id pub-id-type="pmid">26099579</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lopez</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Winter</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>Rivera-Chavez</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Xavier</surname> <given-names>MN</given-names></name>, <name name-style="western"><surname>Poon</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Nuccio</surname> <given-names>SP</given-names></name>, <etal>et al</etal>. <article-title>Phage-mediated acquisition of a type III secreted effector protein boosts growth of salmonella by nitrate respiration</article-title>. <source>MBio</source>. <year>2012</year>;<volume>3</volume>(<issue>3</issue>). Epub 2012/06/14. e00143-12 [pii] mBio.00143-12 [pii].PubMed Central PMCID: PMC3374392.</mixed-citation></ref>
<ref id="ppat.1006129.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jakobson</surname> <given-names>CM</given-names></name>, <name name-style="western"><surname>Tullman-Ercek</surname> <given-names>D</given-names></name>. <article-title>Dumpster Diving in the Gut: Bacterial Microcompartments as Part of a Host-Associated Lifestyle</article-title>. <source>PLoS Pathog</source>. <year>2016</year>;<volume>12</volume>(<issue>5</issue>):<fpage>e1005558</fpage>. PubMed Central PMCID: PMCPMC4865037. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.ppat.1005558" xlink:type="simple">10.1371/journal.ppat.1005558</ext-link></comment> <object-id pub-id-type="pmid">27171216</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lawley</surname> <given-names>TD</given-names></name>, <name name-style="western"><surname>Bouley</surname> <given-names>DM</given-names></name>, <name name-style="western"><surname>Hoy</surname> <given-names>YE</given-names></name>, <name name-style="western"><surname>Gerke</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Relman</surname> <given-names>DA</given-names></name>, <name name-style="western"><surname>Monack</surname> <given-names>DM</given-names></name>. <article-title>Host transmission of Salmonella enterica serovar Typhimurium is controlled by virulence factors and indigenous intestinal microbiota</article-title>. <source>Infect Immun</source>. <year>2008</year>;<volume>76</volume>(<issue>1</issue>):<fpage>403</fpage>–<lpage>16</lpage>. PubMed Central PMCID: PMCPMC2223630. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/IAI.01189-07" xlink:type="simple">10.1128/IAI.01189-07</ext-link></comment> <object-id pub-id-type="pmid">17967858</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lawes</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Maloy</surname> <given-names>S</given-names></name>. <article-title>MudSacI, a transposon with strong selectable and counterselectable markers: use for rapid mapping of chromosomal mutations in Salmonella typhimurium</article-title>. <source>J Bacteriol</source>. <year>1995</year>;<volume>177</volume>(<issue>5</issue>):<fpage>1383</fpage>–<lpage>7</lpage>. PubMed Central PMCID: PMCPMC176747. <object-id pub-id-type="pmid">7868615</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Datsenko</surname> <given-names>KA</given-names></name>, <name name-style="western"><surname>Wanner</surname> <given-names>BL</given-names></name>. <article-title>One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2000</year>;<volume>97</volume>(<issue>12</issue>):<fpage>6640</fpage>–<lpage>5</lpage>. PubMed Central PMCID: PMCPMC18686. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.120163297" xlink:type="simple">10.1073/pnas.120163297</ext-link></comment> <object-id pub-id-type="pmid">10829079</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Staib</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Fuchs</surname> <given-names>TM</given-names></name>. <article-title>Regulation of fucose and 1,2-propanediol utilization by Salmonella enterica serovar Typhimurium</article-title>. <source>Front Microbiol</source>. <year>2015</year>;<volume>6</volume>:<fpage>1116</fpage>. PubMed Central PMCID: PMCPMC4600919. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3389/fmicb.2015.01116" xlink:type="simple">10.3389/fmicb.2015.01116</ext-link></comment> <object-id pub-id-type="pmid">26528264</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mulligan</surname> <given-names>KJ</given-names></name>. <article-title>A Procedure to Determine Diethylene Glycol (2,2'-oxybisethanol) and Ethylene Glycol (1,2-ethanediol) in Glycerin and Selected Products</article-title>. <source>Laboratory Information Bulletin</source>. <year>1996</year>;<volume>12</volume>(<issue>7</issue>):No. 4042.</mixed-citation></ref>
<ref id="ppat.1006129.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stojiljkovic</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Bäumler</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Heffron</surname> <given-names>F</given-names></name>. <article-title>Ethanolamine utilization in <italic>Salmonella typhimurium</italic>: nucleotide sequence, protein expression and mutational analysis of the <italic>cchA cchB eutE eutJ eutG eutH</italic> gene cluster</article-title>. <source>J Bacteriol</source>. <year>1995</year>;<volume>177</volume>:<fpage>1357</fpage>–<lpage>66</lpage>. <object-id pub-id-type="pmid">7868611</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Faber</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Tran</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Byndloss</surname> <given-names>MX</given-names></name>, <name name-style="western"><surname>Lopez</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Velazquez</surname> <given-names>EM</given-names></name>, <name name-style="western"><surname>Kerrinnes</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Host-mediated sugar oxidation promotes post-antibiotic pathogen expansion</article-title>. <source>Nature</source>. <year>2016</year>;<volume>534</volume>(<issue>7609</issue>):<fpage>697</fpage>–<lpage>9</lpage>. PubMed Central PMCID: PMCPMC4939260. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nature18597" xlink:type="simple">10.1038/nature18597</ext-link></comment> <object-id pub-id-type="pmid">27309805</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pal</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Venkova-Canova</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Srivastava</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Chattoraj</surname> <given-names>DK</given-names></name>. <article-title>Multipartite regulation of rctB, the replication initiator gene of Vibrio cholerae chromosome II</article-title>. <source>J Bacteriol</source>. <year>2005</year>;<volume>187</volume>(<issue>21</issue>):<fpage>7167</fpage>–<lpage>75</lpage>. Epub 2005/10/21. 187/21/7167 [pii]. PubMed Central PMCID: PMC1272990. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/JB.187.21.7167-7175.2005" xlink:type="simple">10.1128/JB.187.21.7167-7175.2005</ext-link></comment> <object-id pub-id-type="pmid">16237000</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Simon</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Priefer</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Puhler</surname> <given-names>A</given-names></name>. <article-title>A Broad Host Range Mobilization System for Invivo Genetic-Engineering—Transposon Mutagenesis in Gram-Negative Bacteria</article-title>. <source>Bio-Technology</source>. <year>1983</year>;<volume>1</volume>(<issue>9</issue>):<fpage>784</fpage>–<lpage>91</lpage>.</mixed-citation></ref>
<ref id="ppat.1006129.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Miller</surname> <given-names>VL</given-names></name>, <name name-style="western"><surname>Mekalanos</surname> <given-names>JJ</given-names></name>. <article-title>A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR</article-title>. <source>J Bacteriol</source>. <year>1988</year>;<volume>170</volume>(<issue>6</issue>):<fpage>2575</fpage>–<lpage>83</lpage>. Epub 1988/06/01. PubMed Central PMCID: PMC211174. <object-id pub-id-type="pmid">2836362</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kingsley</surname> <given-names>RA</given-names></name>, <name name-style="western"><surname>Reissbrodt</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Rabsch</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Ketley</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Tsolis</surname> <given-names>RM</given-names></name>, <name name-style="western"><surname>Everest</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Ferrioxamine-mediated Iron(III) utilization by Salmonella enterica</article-title>. <source>Appl Environ Microbiol</source>. <year>1999</year>;<volume>65</volume>(<issue>4</issue>):<fpage>1610</fpage>–<lpage>8</lpage>. Epub 1999/04/02. PubMed Central PMCID: PMC91228. <object-id pub-id-type="pmid">10103258</object-id></mixed-citation></ref>
<ref id="ppat.1006129.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Raffatellu</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>George</surname> <given-names>MD</given-names></name>, <name name-style="western"><surname>Akiyama</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Hornsby</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Nuccio</surname> <given-names>SP</given-names></name>, <name name-style="western"><surname>Paixao</surname> <given-names>TA</given-names></name>, <etal>et al</etal>. <article-title>Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine</article-title>. <source>Cell Host Microbe</source>. <year>2009</year>;<volume>5</volume>(<issue>5</issue>):<fpage>476</fpage>–<lpage>86</lpage>. Epub 2009/05/21. S1931-3128(09)00108-5 [pii]. PubMed Central PMCID: PMC2768556. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.chom.2009.03.011" xlink:type="simple">10.1016/j.chom.2009.03.011</ext-link></comment> <object-id pub-id-type="pmid">19454351</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>